UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 10-K
(Mark One)
 --------
     ( X ) ANNUAL  REPORT  PURSUANT  TO SECTION  13 OR 15 (d) OF THE  SECURITIES
EXCHANGE ACT OF 1934: For the fiscal year ended September 30, 2005

     ( ) TRANSITION  REPORT  PURSUANT TO SECTION 13 OR 15 (d) OF THE  SECURITIES
EXCHANGE  ACT OF 1934:  For the  transition  period  from  _________________  to
______________

Commission File Number:  0-13265

     UCI     MEDICAL      AFFILIATES,      INC.

     (Name of Registrant as Specified in its Charter)
     Delaware                                                   59-2225346
-----------------------------------------------------------------------------
(State  or  Other  Jurisdiction  of
Incorporation  or  Organization)           (IRS Employer Identification Number)

     4416 Forest Drive, Columbia, SC 29206
 ----------------------------------------------
     (Address of Principal Executive Offices) (Zip Code)

                         (803) 782-4278
           (Registrant's Telephone Number, Including Area Code)

     Securities   registered   pursuant  to  Section  12(b)  of  the  Act:  None


     Securities  registered  pursuant to Section 12(g) of the Act: Common Stock,
$.05 par value

     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934 during the  preceding  twelve  months (or for such shorter  period that the
registrant was required to file such  reports),  and (2) has been subject to the
filing requirements for the past 90 days. Yes X No ____

     Indicate by check mark if the disclosure of delinquent  filers  pursuant to
Item 405 of Regulation S-K is not contained  herein,  and will not be contained,
to the best of the  registrant's  knowledge,  in definitive proxy or information
statements  incorporated  by  reference  in Part  III of this  Form  10-K or any
amendment to this Form 10-K. ( X )

     Indicate by check mark whether the registrant is an  accelerated  filer (as
defined in Exchange Act Rule 12b-2) Yes ____ No X

The aggregate market value of voting stock held by non-affiliates of the
registrant on November 14, 2005 was approximately $7,581,820.* The registrant
has no non-voting common equity.

     APPLICABLE ONLY TO REGISTRANTS  INVOLVED IN BANKRUPTCY  PROCEEDINGS  DURING
THE PRECEDING FIVE YEARS

     Indicate by check mark whether the  registrant  has filed all documents and
reports  required  to be filed by  Section  12,  13, or 15(d) of the  Securities
Exchange Act of 1934 subsequent to the  distribution of securities  under a plan
confirmed by a court. Yes X No

                    APPLICABLE ONLY TO CORPORATE REGISTRANTS

The number of shares outstanding of the registrant's common stock, $.05 par
value, was 9,740,472 at September 30, 2005.

                       DOCUMENTS INCORPORATED BY REFERENCE
                                      NONE

* Calculated by excluding all shares held by officers, directors, and
controlling shareholders of registrant without conceding that all such persons
are affiliates of registrant for purposes of the federal securities laws.


<PAGE>


UCI MEDICAL AFFILIATES, INC.

INDEX TO FORM 10-K

<TABLE>
<S>        <C>                                                                                             <C>

         PART I                                                                                             PAGE

Item 1.    Business                                                                                              3

Item 2.    Properties                                                                                            9

Item 3.    Legal Proceedings                                                                                    10

Item 4.    Submission of Matters to a Vote of Security Holders                                                  10


         PART II

Item 5.    Market for Registrant's Common Equity, Related Stockholder Matters and
         Issuer Purchases of Equity Securities                                                                  11

Item 6.    Selected Financial Data                                                                              12

Item 7.  Management's Discussion and Analysis of Financial Condition and Results of Operations                  12

Item 7A. Quantitative and Qualitative Disclosures About Market Risk                                             21

Item 8.    Financial Statements and Supplementary Data                                                          22

Item 9.    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure                 22

Item 9A.   Controls and Procedures                                                                              22

Item 9B.   Other Information                                                                                    23

         PART III

Item 10.   Directors and Executive Officers of the Registrant                                                   24

Item 11.   Executive Compensation                                                                               27

Item 12.   Security Ownership of Certain Beneficial Owners
           and Management and Related Stockholder Matters                                                29

Item 13.   Certain Relationships and Related Transactions                                                         31

Item 14.   Principal Accountant Fees and Services                                                                 33


         PART IV

Item 15.   Exhibits and Financial Statement Schedules                                                             35
</TABLE>





<PAGE>


               Advisory Note Regarding Forward-Looking Statements

Certain of the statements contained in this Report on Form 10-K that are not
historical facts are forward-looking statements subject to the safe harbor
created by the Private Securities Litigation Reform Act of 1995. We caution
readers of this Form 10-K that such forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause our actual
results, performance or achievements to be materially different from those
expressed or implied by such forward-looking statements. Although our management
believes that their expectations of future performance are based on reasonable
assumptions within the bounds of their knowledge of their business and
operations, we have no assurance that actual results will not differ materially
from their expectations. Factors that could cause actual results to differ from
expectations include, among other things, (1) the difficulty in controlling our
costs of providing healthcare and administering our network of centers; (2) the
possible negative effects from changes in reimbursement and capitation payment
levels and payment practices by insurance companies, healthcare plans,
government payors and other payment sources; (3) the difficulty of attracting
primary care physicians; (4) the increasing competition for patients among
healthcare providers; (5) possible government regulations negatively impacting
our existing organizational structure; (6) the possible negative effects of
prospective healthcare reform; (7) the challenges and uncertainties in the
implementation of our expansion and development strategy; (8) the dependence on
key personnel; (9) adverse conditions in the stock market, the public debt
market, and other capital markets (including changes in interest rate
conditions); (10) the strength of the United States economy in general and the
strength of the local economies in which we conduct operations may be different
than expected resulting in, among other things, a reduced demand for practice
management services; (11) the demand for our products and services; (12)
technological changes; (13) the ability to increase market share; (14) the
adequacy of expense projections and estimates of impairment loss; (15) the
impact of change in accounting policies by the Securities and Exchange
Commission; (16) unanticipated regulatory or judicial proceedings; (17) the
impact on our business, as well as on the risks set forth above, of various
domestic or international military or terrorist activities or conflicts; (18)
other factors described in this report and in our other reports filed with the
Securities and Exchange Commission; and (19) our success at managing the risks
involved in the foregoing.


                                     PART I

Item 1.  Business

General

UCI Medical Affiliates, Inc. ("UCI") is a Delaware corporation incorporated on
August 25, 1982. Operating through its wholly-owned subsidiary, UCI Medical
Affiliates of South Carolina, Inc. ("UCI-SC"), UCI provides nonmedical
management and administrative services for a network of 47 freestanding medical
centers, 46 of which are located throughout South Carolina and one is located in
Knoxville, Tennessee (29 operating as Doctors Care in South Carolina, one as
Doctors Care in Knoxville, Tennessee, 15 as Progressive Physical Therapy
Services in South Carolina, one as Luberoff Pediatrics in South Carolina, and
one as Carolina Orthopedic & Sports Medicine in South Carolina). We refer to
these 47 medical centers as the "centers" throughout this report.

Organizational Structure

Federal law and the laws of many states, including South Carolina and Tennessee,
generally specify who may practice medicine and limit the scope of relationships
between medical practitioners and other parties. Under such laws, UCI and UCI-SC
are prohibited from practicing medicine or exercising control over the provision
of medical services. In order to comply with such laws, all medical services at
the centers are provided by or under the supervision of Doctors Care, P.A.,
Progressive Physical Therapy, P.A. ("PPT"), Carolina Orthopedic & Sports
Medicine, P.A. ("COSM") or Doctors Care of Tennessee, P.C. (the four together as
the "P.A."), each of which has contracted with UCI-SC to be the sole provider of
all non-medical direction and supervision of the centers operating in its
respective state of organization. We refer to the P.A., UCI, and UCI-SC (the
three together as the "Company") throughout this report as "we", "us", and
"our." The P.A. is organized so that all physician services are offered by the
physicians who are employed by the P.A. Neither UCI nor UCI-SC employ practicing
physicians as practitioners, exert control over their decisions regarding
medical care, or represent to the public that it offers medical services.



<PAGE>


UCI-SC has entered into an Administrative Services Agreement with each P.A.
pursuant to which UCI-SC performs all non-medical management of the P.A. and has
exclusive authority over all aspects of the business of the P.A. (other than
those directly related to the provision of patient medical services or as
otherwise prohibited by state law). The non-medical management provided by
UCI-SC includes, among other functions, treasury and capital planning, financial
reporting and accounting, pricing decisions, patient acceptance policies,
setting office hours, contracting with third party payors, and all
administrative services. UCI-SC provides all of the resources (systems,
procedures, and staffing) to bill third party payors or patients and provides
all of the resources for cash collection and management of accounts receivables,
including custody of the lockbox where cash receipts are deposited. From the
cash receipts, UCI-SC pays all physician salaries and operating costs of the
centers and of UCI-SC. Compensation guidelines for the licensed medical
professionals at the P.A. are set by UCI-SC, and UCI-SC establishes guidelines
for selecting, hiring, and firing the licensed medical professionals. UCI-SC
also negotiates and executes substantially all of the provider contracts with
third party payors. UCI-SC does not loan or otherwise advance funds to the P.A.
for any purpose.

The P.A. and UCI-SC share a common management team. In each case, the same
individuals serve in the same executive offices of each entity.

UCI-SC believes that the services it provides to the P.A. do not constitute the
practice of medicine under applicable laws. Because of the unique structure of
the relationships described above, many aspects of our business operations have
not been the subject of state or federal regulatory interpretation. We have no
assurance that a review of our business by the courts or regulatory authorities
will not result in a determination that could adversely affect our operations or
that the health care regulatory environment will not change so as to restrict
our existing operations or future expansion.

The Centers

The centers are staffed by licensed physicians, physical therapists, other
healthcare providers, medical support staff, and administrative support staff.
The medical support staff includes licensed nurses, certified medical
assistants, laboratory technicians, and registered radiographic technologists.

The centers typically are open for extended hours (weekends and evenings) and
are out-patient care only. When hospitalization or specialty care is needed,
referrals to appropriate specialists are made.

Our centers are broadly distributed throughout the State of South Carolina, and
one is in Knoxville, Tennessee. Twenty primary care centers are in the Columbia,
South Carolina region (including six physical therapy offices, one pediatric
office and one Orthopedic office), eleven in the Charleston, South Carolina
region (including five physical therapy offices), five in the Myrtle Beach,
South Carolina region, two in the Aiken, South Carolina region (including one
physical therapy office), eight in the Greenville-Spartanburg, South Carolina
region (including three physical therapy offices), and one in Knoxville,
Tennessee.

Medical Services Provided at the Centers

Our centers offer out-patient medical care for treatment of acute, episodic, and
some chronic medical problems. The centers provide a broad range of medical
services that would generally be classified as within the scope of family
practice, primary care, and occupational medicine. We also offer pediatric and
orthopedic medical services at two of our centers. Licensed medical providers,
nurses, and auxiliary support personnel provide the medical services. The
services provided at the centers include, but are not limited to, the following:

o    Routine care of general medical problems, including colds, flu, ear
     infections, hypertension, asthma, pneumonia, and other conditions typically
     treated by primary care providers;

     o Treatment of injuries, such as simple fractures,  dislocations,  sprains,
bruises, and cuts;

     o Minor surgery, including suturing of lacerations and removal of cysts and
foreign bodies;

     o Diagnostic  tests,  such as x-rays,  electrocardiograms,  complete  blood
counts, and urinalyses; and

o Occupational and industrial medical services, including drug testing, workers'
compensation cases, and physical examinations.

Patient Charges and Payments

The fees charged to a patient are determined by the nature of medical services
rendered. Our management believes that the charges at our centers are
significantly lower than the charges of hospital emergency departments and are
generally competitive with the charges of local physicians and other providers
in the area and for the majority of patients the charges are established by
third-party payors.

Our centers accept payment from a wide range of sources. These include patient
payments at time of service (by cash, check, or credit card), patient billing
and assignment of insurance benefits (including Blue Cross Blue Shield, Workers'
Compensation, and other private insurance). Managed care billings represent the
most significant source of revenues. We also provide services for members of the
four largest health maintenance organizations ("HMOs") operating in South
Carolina - BlueChoice HealthPlan ("BCHP") [formerly known as Companion
Healthcare Corporation `CHC'], HMO Blue, Cigna/HealthSource South Carolina,
Inc., and Carolina Care Plan.

Revenues generated from billings to Blue Cross Blue Shield of South Carolina
("BCBS") and its subsidiaries, BCHP and Companion Property and Casualty
Insurance Company ("CP&C"), totaled approximately 40%, 39%, and 38% of the
Company's total revenues for fiscal years 2005, 2004, and 2003, respectively.

The following table breaks out our approximate revenue and patient visits by
revenue source for fiscal year 2005:

<TABLE>
<S>                                   <C>                        <C>

                                        Percent of                 Percent of
            Payor                     Patient Visits                Revenue
-------------------------------       ---------------            -------------


                                              16                          11
Patient Pay
                                                                            4
Employer Paid                         9
                                                                            7
HMO                                   6
                                                                          12
Workers' Compensation                 10
                                                                          11
Medicare/Medicaid                     14
                                                                          52
Managed Care Insurance                42

Other  (Commercial  Indemnity,                                              3
Champus, etc.)                        3
                                      ---------------            -------------
                                      ---------------            ---------------
                                                 100                    100
                                      ===============            =============
</TABLE>

In accordance with the Administrative Services Agreements described previously,
UCI-SC, as the agent for each P.A., processes all payments for the P.A. (When
payments for the P.A. are received, they are deposited in accounts owned by each
P.A. and are automatically transferred to a lockbox account owned by UCI-SC.) In
no event are the physicians entitled to receive such payments. The patient mix
in no way affects our management service fees per the Administrative Services
Agreement.

Fee Arrangements

Medical services traditionally have been provided on a fee-for-service basis
with insurance companies assuming responsibility for paying all or a portion of
such fees. The increase in medical costs under traditional indemnity health care
plans has been caused by a number of factors. These factors include: (i) the
lack of incentives on the part of health care providers to deliver
cost-effective medical care; (ii) the absence of controls over the utilization
of costly specialty care physicians and hospitals; (iii) a growing and aging
population that requires increased health care expenditures; and (iv) the
expense involved with the introduction and use of advanced pharmaceuticals and
medical technology.

As a result of escalating health care costs, employers, insurers, and
governmental entities all have sought cost-effective approaches to the delivery
of and payment for quality health care services. HMOs and other managed health
care organizations have emerged as integral components in this effort. HMOs
enroll members by entering into contracts with employer groups or directly with
individuals to provide a broad range of health care services for a capitation
payment (we have no capitation arrangements at the present time) or a discounted
fee-for-service schedule, with minimal or no deductibles or co-payments required
of the members. HMOs, in turn, contract with health care providers like us to
administer medical care to HMO members. These contracts provide for payment to
us on a discounted fee-for-service basis.

Certain third party payors constantly seek various alternatives for reducing
medical costs, some of which, if implemented, could affect our payment levels.
Our management cannot predict whether changes in present payment methods will
affect payments for services provided by the centers and, if so, whether they
will have an adverse impact upon our business.

Competition and Marketing

All of our centers face competition, in varying degrees, from hospital emergency
rooms, private doctor's offices, other competing freestanding medical centers,
and physical therapy offices. Some of these providers have financial resources
that are greater than our resources. In addition, traditional sources of medical
services, such as hospital emergency rooms and private physicians, have had, in
the past, a higher degree of recognition and acceptance by patients than centers
such as ours. Our centers compete on the basis of accessibility, including
evening and weekend hours, walk-in care, as well as limited appointment
opportunities, and the attractiveness of our state-wide network to large
employers and third party payors. We have implemented substantial marketing
efforts, which currently include radio and television advertisements. We have
also added regional marketing representatives, developed focused promotional
material, and initiated a newsletter for employers promoting our activities.

Government Regulation

As participants in the health care industry, our operations and relationships
are subject to extensive and increasing regulation by a number of governmental
entities at the federal, state, and local levels.

Limitations on the Corporate Practice of Medicine

Federal law and the laws of many states, including South Carolina and Tennessee,
generally specify who may practice medicine and limit the scope of relationships
between medical practitioners and other parties. Under such laws, business
corporations such as UCI and UCI-SC are prohibited from practicing medicine or
exercising control over the provision of medical services. In order to comply
with such laws, all medical services at our centers are provided by or are under
the supervision of the P.A. pursuant to contracts with UCI-SC. The P.A. is
organized so that the physicians who are employed by the P.A. offer all
physician services. Neither UCI nor UCI-SC employs practicing physicians as
practitioners, exerts control over any physician's decisions regarding medical
care, or represents to the public that it offers medical services.

As described previously, UCI-SC has entered into an Administrative Services
Agreement with each P.A. to perform all non-medical management of the applicable
P.A. and has exclusive authority over all aspects of the business of the P.A.
(other than those directly related to the provision of patient medical services
or as otherwise prohibited by state law). (See Item 1. Business - Organizational
Structure.)

Because of the unique structure of the relationships existing between UCI-SC and
each P.A., many aspects of our business operations have not been the subject of
state or federal regulatory interpretation. We have no assurance that a review
by the courts or regulatory authorities of the business formerly or currently
conducted by us will not result in a determination that could adversely affect
our operations or that the healthcare regulatory environment will not change so
as to restrict the existing operations or any potential expansion of our
business.

Third Party Payments

Approximately eleven percent of our revenue is derived from payments made by
government-sponsored healthcare programs (principally, Medicare and Medicaid).
As a result, any change in the laws, regulations, or policies governing
reimbursements could adversely affect our operations. State and federal civil
and criminal statutes also impose substantial penalties, including civil and
criminal fines and imprisonment, on healthcare providers that fraudulently or
erroneously bill governmental or other third-party payors for healthcare
services. We believe we are in material compliance with such laws, but we have
no assurance that our activities will not be challenged or scrutinized by
governmental authorities.

Federal Anti-Kickback and Self-Referral Laws

Certain provisions of the Social Security Act, commonly referred to as the
"Anti-kickback Statute," prohibit the offer, payment, solicitation, or receipt
of any form of remuneration in return for the referral of Medicare or state
health program patients or patient care opportunities, or in return for the
recommendation, arrangement, purchase, lease, or order of items or services that
are covered by Medicare or state health programs. Although we believe that we
are not in violation of the Anti-kickback Statute or similar state statutes, our
operations do not fit within any of the existing or proposed federal safe
harbors.

The Office of the Inspector General (the "OIG"), the government office that is
charged with the enforcement of the federal Anti-kickback Statute, issued an
advisory opinion regarding a proposed management services contract unrelated to
us that involved a cost plus a percentage of net revenue payment arrangement
("Advisory Opinion 98-4"). Based on its analysis of the intent and scope of the
Anti-kickback Statute, the OIG determined that it could not approve the
arrangement because the structure of the management agreement raised the
following concerns under the Anti-kickback Statute: (i) the agreement might
include financial incentives to increase patient referrals; (ii) the agreement
did not include any controls to prevent over utilization; and (iii) the
percentage billing arrangement may include financial incentives that increase
the risk of abusive billing practices. The OIG opinion did not find that the
management arrangement violated the Anti-kickback Statute, rather that the
arrangement may involve prohibited remuneration absent sufficient controls to
minimize potential fraud and abuse. An OIG advisory opinion is only legally
binding on the Department of Health and Human Services (including the OIG) and
the requesting party and is limited to the specific conduct of the requesting
party because additional facts and circumstances could be involved in each
particular case. Accordingly, we believe that Advisory Opinion 98-4 does not
have broad application to the provision by UCI and UCI-SC of nonmedical
management and administrative services for the centers. We also believe that we
have implemented appropriate controls to ensure that the arrangements between
UCI and UCI-SC and the centers do not result in abusive billing practices or the
over utilization of items and services paid for by federal health programs.

The applicability of the Anti-kickback Statute to many business transactions in
the health care industry, including the service agreements with the centers and
the development of ancillary services by UCI and UCI-SC, has not been subject to
any significant judicial and regulatory interpretation. We believe that although
remuneration for the management services is provided for under our service
agreements with the centers, UCI and UCI-SC are not in a position to make or
influence referrals of patients or services reimbursed under Medicare or state
health programs to the centers. In addition, UCI and UCI-SC is not a separate
provider of Medicare or state health program reimbursed services. Consequently,
we do not believe that the service and management fees payable to UCI and UCI-SC
should be viewed as remuneration for referring or influencing referrals of
patients or services covered by such programs as prohibited by the Anti-kickback
Statute.

The U.S. Congress in the Omnibus Budget Reconciliation Act of 1993 enacted
significant prohibitions against physician referrals. Subject to certain
exemptions, a physician or a member of his or her immediate family is prohibited
from referring Medicare or Medicaid patients to an entity providing "designated
health services" in which the physician has an ownership or investment interest
or with which the physician has entered into a compensation arrangement. While
we believe we are currently in compliance with such legislation, future
regulations could require us to modify the form of our relationships with
physician groups.

State Anti-Kickback and Self-Referral Laws

Some states have also enacted similar self-referral laws, and we believe that
more states will likely follow. We believe that our practices fit within
exemptions contained in such laws. Nevertheless, in the event we expand our
operations to certain additional jurisdictions, structural and organizational
modifications of our relationships with physician groups might be required to
comply with new or revised state statutes. Such modifications could adversely
affect our operations.

Through UCI's wholly owned subsidiary, UCI-SC, we provide non-medical management
and administrative services to the centers in South Carolina and Tennessee.
South Carolina and Tennessee have adopted anti-kickback and self-referral laws
that regulate financial relationships between health care providers and entities
that provide health care services. The following is a summary of the applicable
state anti-kickback and self-referral laws.

 South Carolina

South Carolina's Provider Self-Referral Act of 1993 generally provides that a
health care provider may not refer a patient for the provision of any designated
health service to an entity in which the health care provider is an investor or
has an investment interest. Under our current operations, we do not believe UCI
or UCI-SC is an entity providing designated health services for purposes of the
South Carolina Provider Self-Referral Act. The centers provide all health care
services to patients through employees of the P.A. No provider investors in the
P.A. refer patients to the centers for designated health care services.
Accordingly, under South Carolina law, we believe that the provider
self-referral prohibition would not apply to our centers or operations in South
Carolina.

In addition to self-referral prohibitions, South Carolina's Provider
Self-Referral Act of 1993 also prohibits the offer, payment, solicitation, or
receipt of a kickback, directly or indirectly, overtly or covertly, in cash or
in kind, for referring or soliciting patients. We believe that payment
arrangements are reasonable compensation for services rendered and do not
constitute payments for referrals.

Tennessee

The Tennessee physician conflict of interest/disclosure law provides that
physicians are free to enter into lawful contractual relationships, including
the acquisition of ownership interests in health facilities. The law further
recognizes that these relationships can create potential conflicts of interests,
which shall be addressed by the following: (a) the physician has a duty to
disclose to the patient or referring colleagues such physician's ownership
interest in the facility or therapy at the time of referral and prior to
utilization; (b) the physician shall not exploit the patient in any way, as by
inappropriate or unnecessary utilization; (c) the physician's activities shall
be in strict conformity with the law; (d) the patient shall have free choice
either to use the physician's proprietary facility or therapy or to seek the
needed medical services elsewhere; and (e) when a physician's commercial
interest conflicts so greatly with the patient's interest as to be incompatible,
the physician shall make alternative arrangements for the care of the patient.

We believe that Tennessee's conflict of interest/disclosure law does not apply
to our current operations because UCI and UCI-SC are not providers of health
services. The centers provide all health care services to patients through
employees of the P.A. Even if the Tennessee conflict of interest/disclosure law
were to apply, our internal quality assurance/utilization review programs will
help identify any inappropriate utilization by a center.

Tennessee also has a law regulating healthcare referrals. The general rule is
that a physician who has an investment interest in a healthcare entity shall not
refer patients to the entity unless a statutory exception exists. A healthcare
entity is defined as an entity that provides healthcare services. We believe
that UCI and UCI-SC do not fit within the definition of a "healthcare entity"
because UCI and UCI-SC are not providers of healthcare services. The centers
provide all health care services to patients through employees of the P.A. No
provider investors in the P.A. refer patients for designated health care
services except the sole physician shareholder of the P.A. We believe that
referrals by the sole shareholder of the P.A. come within a statutory exception.
Accordingly, under Tennessee law, we believe that the provider self-referral
prohibition would not apply to our center or operations in Tennessee.

Tennessee's anti-kickback provision prohibits a physician from making payments
in exchange for the referral of a patient. In addition, under Tennessee law a
physician may not split or divide fees with any person for referring a patient.
The Tennessee Attorney General has issued opinions that determined that the
fee-splitting prohibition applied to management services arrangements. The
Tennessee fee-splitting prohibition contains an exception for reasonable
compensation for goods or services. We believe that the payment arrangements
between UCI and UCI-SC, as applicable, and the centers are reasonable
compensation for services rendered and do not constitute payments for referrals
or a fee-splitting arrangement.

Antitrust Laws

Because each of the P.A. is a separate legal entity, each may be deemed a
competitor subject to a range of antitrust laws that prohibit anti-competitive
conduct, including price fixing, concerted refusals to deal, and division of
market. We believe we are in compliance with such state and federal laws that
may affect our development of integrated healthcare delivery networks, but we
have no assurance that a review of our business by courts or regulatory
authorities will not result in a determination that could adversely affect our
operations.

Healthcare Reform

As a result of the continued escalation of healthcare costs and the inability of
many individuals to obtain health insurance, numerous proposals have been or may
be introduced in the U.S. Congress and in state legislatures relating to
healthcare reform. We have no assurance as to the ultimate content, timing, or
effect of any healthcare reform legislation, nor can we estimate at this time
the impact of potential legislation that may be material on us.

Regulation of Risk Arrangements and Provider Networks

Federal and state laws regulate insurance companies, health maintenance
organizations, and other managed care organizations. Generally, these laws apply
to entities that accept financial risk. Certain of the risk arrangements entered
into by us could possibly be characterized by some states as the business of
insurance. We, however, believe that the acceptance of capitation payments by a
healthcare provider does not constitute the conduct of the business of
insurance. Many states also regulate the establishment and operation of networks
of healthcare providers. Generally, these laws do not apply to the hiring and
contracting of physicians by other healthcare providers. South Carolina and
Tennessee do not currently regulate the establishment or operation of networks
of healthcare providers except where such entities provide utilization review
services through private review agents. We believe that we are in compliance
with these laws in the states in which we currently do business, but we have no
assurance that future interpretations of these laws by the regulatory
authorities in South Carolina, Tennessee, or the states in which we may expand
in the future will not require licensure of our operations as an insurer or
provider network or a restructuring of some or all of our operations. In the
event we are required to become licensed under these laws, the licensure process
can be lengthy and time consuming and, unless the regulatory authority permits
us to continue to operate while the licensure process is progressing, we could
experience a material adverse change in our business while the licensure process
is pending. In addition, many of the licensing requirements mandate strict
financial and other requirements that we may not immediately be able to meet.
Further, once licensed, we would be subject to continuing oversight by and
reporting to the respective regulatory agency.

HIPPA

Under the Health Insurance Portability and Accountability Act of 1996 ("HIPPA"),
the Secretary of Health and Human Services ("HHS") has adopted national data
interchange standards for some types of electronic transactions and the data
elements used in those transactions; adopted security standards to protect the
confidentiality, integrity and availability of patient health information; and
adopted privacy standards to prevent inappropriate access, use and disclosure of
patient health information. In December 2000, HHS published the final privacy
regulations that took effect in April 2003. These regulations restrict the use
and disclosure of individually identifiable health information without the prior
informed consent of the patient. In February 2003, HHS published the final
security regulations, which took effect in April 2005. These regulations mandate
that healthcare facilities implement operational, physical and technical
security measures to reasonably prevent accidental, negligent or intentional
inappropriate access or disclosure of patient health information. We have made
changes to our business operations to support these regulatory requirements. We
feel that our current operations fully support the requirements to comply with
the above regulations.

Employees

As of September 30, 2005, we had 675 employees (516 on a full-time equivalent
basis). This amount includes 110 medical providers employed by the P.A.

Item 2.  Properties

All but one of our primary care center's facilities are leased. The properties
are generally located on well-traveled major highways, with easy access. Each
property offers free, off-street parking immediately adjacent to the center. One
center is leased from a physician employee of the P.A.



<PAGE>


Our centers are broadly distributed throughout the State of South Carolina, and
one is in Knoxville, Tennessee. Twenty primary care centers are in the Columbia,
South Carolina region (including six physical therapy offices, one pediatric
office, and one Orthopedic office), eleven in the Charleston, South Carolina
region (including five physical therapy offices), five in the Myrtle Beach,
South Carolina region, two in the Aiken, South Carolina region (including one
physical therapy office), eight in the Greenville-Spartanburg, South Carolina
region (including three physical therapy offices), and one in Knoxville,
Tennessee. Our corporate offices are located on the second floor of one of the
Columbia, South Carolina locations. The centers are all free-standing buildings
in good repair.

Item 3.  Legal Proceedings

We are a party to various claims, legal activities and complaints arising in the
normal course of business. In the opinion of management and legal counsel,
aggregate liabilities, if any, arising from legal actions would not have a
material adverse effect on our financial position.

Item 4.  Submission of Matters to a Vote of Security Holders

On July 26, 2005, UCI's annual meeting of the shareholders was held and the
following actions were taken:

     Holders of UCI's common stock  represented at the meeting voted to re-elect
Joseph A. Boyle,  CPA, Ashby M. Jordan,  M.D., and John M. Little,  Jr., M.D. to
the  Board of  Directors  for  terms  expiring  at the 2008  annual  meeting  of
stockholders, as follows:

<TABLE>
<S>               <C>                                 <C>             <C>             <C>

                                                        Number                          Withhold
                                                         Voting           For           Approval
                                                      ------------    ------------    -------------

                  Joseph A. Boyle, CPA                  9,033,790       8,684,770          349,020
                  Ashby M. Jordan, M.D.                 9,033,790       8,670,270          363,520
                  John M. Little, Jr., M.D.             9,033,790       8,684,770          349,020
</TABLE>


Holders of UCI's common stock represented at the meeting voted to ratify the
appointment of Scott McElveen, L.L.P. as our independent auditors for the fiscal
year ended September 30, 2005, as follows:

<TABLE>
<S>                                   <C>             <C>              <C>            <C>

                                        Number
                                        Voting            For           Against         Abstain
                                     -------------    ------------     -----------    -------------
                                        9,033,790       8,685,878         344,872            3,040
</TABLE>



<PAGE>



                                     PART II

     Item 5. Market for Registrant's Common Equity,  Related Stockholder Matters
and Issuer Purchases of Equity Securities

Until October 19, 1998, UCI's common stock was traded on the NASDAQ SmallCap
Market under the symbol UCIA. On October 20, 1998, UCI's common stock was
delisted for trading on the NASDAQ SmallCap Market as a consequence of UCI's
failure to meet certain quantitative requirements under the NASD's expanded
listing criteria. Trading in UCI's common stock is currently conducted in the
over-the-counter market. The prices set forth below indicate the high and low
bid prices reported on the over-the-counter bulletin board. The quotations
reflect inter-dealer prices without retail markup, markdown, or commission and
may not necessarily reflect actual transactions.
<TABLE>
<S>  <C>                                                      <C>              <C>

                                                                      Bid Price
                                                              --------------------------
                                                                High             Low
                                                              ---------        ---------
Fiscal Year Ended September 30, 2005

     1st quarter (10/01/04 - 12/31/04)                           $2.30            $1.08
     2nd quarter (01/01/05 - 03/31/05)                            2.02             1.55
     3rd quarter (04/01/05 - 06/30/05)                            4.02             1.99
     4th quarter (07/01/05 - 09/30/05)                            3.24             2.87
</TABLE>

Fiscal Year Ended September 30, 2004
<TABLE>
<S>  <C>                                                         <C>             <C>

     1st quarter (10/01/03 - 12/31/03)                           $1.80            $1.20
     2nd quarter (01/01/04 - 03/31/04)                            3.00             1.67
     3rd quarter (04/01/04 - 06/30/04)                            3.00             1.46
     4th quarter (07/01/04 - 09/30/04)                            1.90             1.04
</TABLE>

As of September 30, 2005, there were 261 stockholders of record of UCI's common
stock, excluding individual participants in security position listings.

UCI has not paid cash dividends on its common stock since its inception and has
no plans to declare cash dividends in the foreseeable future.

No equity securities of UCI were sold by UCI or repurchased by UCI during the
fiscal year ended September 30, 2005.



<PAGE>


Item 6.  Selected Financial Data
<TABLE>
<S>                                            <C>             <C>             <C>             <C>              <C>

                                               STATEMENT OF OPERATIONS DATA
----------------------------------------------------------------------------------------------------------------------------
                                                                  (In thousands, except per share data)
                                               -----------------------------------------------------------------------------
                                               -----------------------------------------------------------------------------
                                                                     For the year ended September 30,
                                               -----------------------------------------------------------------------------
                                               ----------- -- ------------- -- ------------ -- ------------ -- -------------
                                                  2005            2004            2003            2002             2001
                                               -----------    -------------    ------------    ------------    -------------

Revenues                                          $56,642          $47,474         $43,518         $38,527          $38,117
Net income (loss)                                   7,541            3,214           2,375           1,394          (1,475)
Basic earnings (loss) per share                       .77              .33             .25            .14             (.15)
Diluted earnings (loss) per share                     .76              .33             .25            .14             (.15)
Basic weighted average number of
    shares outstanding                              9,740            9,718           9,650           9,651            9,651
Diluted weighted average number of
    shares outstanding                              9,879            9,718           9,650           9,651            9,651
</TABLE>




<PAGE>

<TABLE>
<S>                                             <C>              <C>           <C>             <C>             <C>

                                                    BALANCE SHEET DATA

                                                ----------------------------------------------------------------------------
                                                                      At September 30, (in thousands)
                                                ----------------------------------------------------------------------------
                                                ------------ -- ---------- -- ------------ -- ------------- -- -------------
                                                   2005           2004           2003             2002             2001
                                                ------------    ----------    ------------    -------------    -------------

Working capital                                     $ 6,690        $3,228         $ 2,925          $ 2,515         $(6,245)
Property and equipment, net                           6,013         4,845           4,028            3,765            3,977
Total assets                                         23,399        17,549          15,859           14,517           14,983
Long-term debt, including current portion             4,758         3,504           3,327            4,079            7,210
Stockholders' equity (deficiency)                    13,321         5,780           2,566              190          (1,204)
</TABLE>

See Note 1 to the accompanying financial statements, which discusses the impact
of accounting changes on the information reflected above in selected financial
data and the reclassification of certain prior year amounts.

     Item 7.  Management's  Discussion  and Analysis of Financial  Condition and
Results of Operations

The following discussion and analysis provides information that we believe is
relevant to an assessment and understanding of our consolidated results of
operations and financial condition. This discussion should be read in
conjunction with the consolidated financial statements and notes thereto.

Critical Accounting Policies

We have adopted accounting policies that we believe will result in an accurate
presentation of the financial statements. We consider critical accounting
policies to be those that require more significant judgments and estimates in
the preparation of our financial statements and include the following: (1)
revenue recognition; (2) allowance for doubtful accounts; (3) consideration of
impairment of intangible assets; and (4) valuation reserve on net deferred tax
assets.

Revenue recognition -

We record revenues at the estimated net amount that we expect to receive from
patients, employers, third party payors, and others at the time we perform the
services. We record contractual adjustments when we prepare the related bills to
our customers as we bill some third parties at discounted and negotiated
amounts. Whenever we bill at the discounted amounts, we do not need to estimate
third party settlements.

Allowance for doubtful accounts -

We maintain our allowance for doubtful accounts for estimated losses, which may
result from the inability of our customers to make required payments. We base
our allowance on the likelihood of recoverability of accounts receivable
considering such factors as past experience and current collection trends.
Factors taken into consideration in estimating the allowance include: amounts
past due, in dispute, or a client that we believe might be having financial
difficulties. If economic, industry, or specific customer business trends worsen
beyond earlier estimates, we increase the allowance for doubtful accounts by
recording additional bad debt expense.

Consideration of impairment of intangible assets -

We evaluate the recovery of the carrying amount of excess of cost over fair
value of assets acquired by determining if a permanent impairment has occurred.
This evaluation is done annually on September 30th of each year or more
frequently if indicators of permanent impairment arise. Indicators of a
permanent impairment include, among other things, significant adverse change in
legal factors or the business climate, an adverse action by a regulator,
unanticipated competition, loss of key personnel or allocation of goodwill to a
portion of the business that is to be sold or otherwise disposed. At such time
as impairment is determined, the intangible assets are written off during that
period.

Valuation reserve on net deferred tax assets -

We record a valuation allowance to reduce our deferred tax assets to the amount
that management considers is more likely than not to be realized. Based upon our
current financial position, results from operations, and our forecast of future
earnings, we do not believe we currently need a valuation reserve.

Company structure

     Our  consolidated  financial  statements  include  the  accounts of UCI and
UCI-SC. Such consolidation is required under FIN 46, as revised. We believe that
the P.A.  is a viable  interest  entity  (VIE) as defined by FIN 46, as revised.
However, if the P.A. is subsequently  determined not to be a VIE, the P.A. would
continue  to  be  consolidated  with  UCI  under  the  guidance  of  EITF  97-2,
"Application  of FASB  Statement  No. 94 and A.P.B.  Opinion No. 16 to Physician
Practice  Management  Entities  and  Certain  Other  Entities  with  Contractual
Management Arrangements". UCI-SC, in its sole discretion, can effect a change in
the nominee  shareholder of each P.A. at any time for a payment of $100 from the
new nominee shareholder to the old nominee shareholder, with no limits placed on
the identity of any new nominee  shareholder and no adverse impact  resulting to
any of UCI-SC or the P.A. from such change.

In addition to the nominee shareholder arrangement described above, UCI-SC has
entered into an Administrative Service Agreement with each P.A. As a consequence
of the nominee shareholder arrangement and the Administrative Service Agreement,
we have a long-term financial interest in the affiliated practices of each P.A.
According to the application of FASB Statement No. 94 (Consolidation of All
Majority-Owned Subsidiaries), and FIN No. 46, as revised (Consolidation of
Variable Interest Entities), UCI must consolidate the results of the affiliated
practices with those of UCI.

Approximately 99% of the physicians employed by the P.A. are paid on an hourly
basis for time scheduled and worked at the medical centers. Approximately 30% of
the physicians have incentive compensation arrangements; however, no amounts
were accrued or paid that were significant during our three prior fiscal years.
We base any incentive compensation upon a percentage of non-ancillary
collectible charges for services performed by a provider. As of September 30,
2005 and 2004, the P.A. employed 110 and 111 medical providers, respectively.

The net assets of the P.A. are not material for any period presented, and
intercompany accounts and transactions have been eliminated.

We allocate all indirect costs incurred at the corporate office to the centers.
Therefore, all discussions below are intended to be in the aggregate for us as a
whole.

Chapter 11 Bankruptcy Filing

On November 2, 2001, we filed a voluntary petition for reorganization under
Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy
Court for the District of South Carolina (the "Bankruptcy Court"). By August 8,
2002, the Bankruptcy Court confirmed each of our Plans of Reorganization (the
"Plans"), as amended, and we have, therefore, emerged from Chapter 11 protection
of the Court.



<PAGE>


Comparison of Fiscal Year Ended September 30, 2005 to Fiscal Year Ended
September 30, 2004 and Comparison of Fiscal Year Ended September 30, 2004 to
Fiscal Year Ended September 30, 2003

Revenues of $56,642,000 in fiscal year 2005 reflected an increase of
approximately 19% from the fiscal year 2004 revenues of $47,474,000, which
reflected an increase of approximately 9% from the amount reported for fiscal
year 2003. The following reflects revenue trends from fiscal year 2001 through
fiscal year 2005:
<TABLE>
<S>                      <C>                 <C>                 <C>               <C>                 <C>

                                               For the year ended September 30, (in thousands)

                            2005                2004               2003                 2002               2001
                         ------------       -------------       ------------       ---------------     --------------

Revenues                  $   56,642        $    47,474         $    43,518        $    38,527         $    38,117
Operating Costs               42,310             36,733              33,264             31,069              29,710
Operating Margin              14,332             10,741              10,254              7,458               8,407
</TABLE>

The increase in revenues from fiscal year 2004 to fiscal year 2005 is attributed
to the opening of four new centers and an increase in the number of patient
visits and improved revenue per patient.

The number of our centers remained constant at 36 from September 30, 2001 to
September 30, 2002. The number of centers in operation increased from 36 to 41
during fiscal year 2003. We added seven physical therapy offices (two in the
Greenville-Spartanburg, South Carolina region, three in the Columbia, South
Carolina region, and two in the Charleston, South Carolina region), and we
closed two offices during fiscal year 2003 (one in the Tennessee region and one
in the Greenville-Spartanburg, South Carolina region). The number of centers
increased from 41 to 43 during fiscal year 2004. We added two physical therapy
offices (one in the Columbia, South Carolina region and one in the Charleston,
South Carolina region). The number of centers in operation increased from 43 to
47 during fiscal year 2005. We added three Doctors Care offices (two in the
Columbia, South Carolina region and one in the Myrtle Beach, South Carolina
region) and one physical therapy office (in the Charleston, South Carolina
region).

During the past three fiscal years, we have continued our services provided to
members of HMOs. In these arrangements, we, through the P.A., act as the
designated primary caregiver for members of HMOs who have selected one of our
centers or providers as their primary care provider. In fiscal year 1994, we
began participating in an HMO operated by BlueChoice HealthPlan ("BCHP")
[formerly known as Companion Healthcare Corporation `CHC'] and Companion
Property & Casualty Insurance Company ("CP&C"), wholly owned subsidiaries of
Blue Cross Blue Shield of South Carolina ("BCBS"). BCBS, through BCHP, is a
primary stockholder of UCI. Including our arrangement with BCHP and CP&C, we now
participate in four HMOs and are the primary care "gatekeeper" for more than
7,000 lives in fiscal year 2005; 8,000 lives in fiscal year 2004; and 9,000
lives in fiscal year 2003. As of September 30, 2005, all of these HMOs use a
discounted fee-for-service basis for payment. HMOs do not, at this time, have a
significant penetration into the South Carolina market. We are not certain if
the market share of HMOs will grow in the areas in which we operate clinics.
(See Footnote 14 to audited consolidated Financial Statements for information on
related parties.)

Sustained revenues in fiscal years 2005, 2004, and 2003 also reflect our
occupational medicine and industrial health services (these revenues are
referred to as "employer paid" and "workers' compensation" on the table depicted
below). Approximately 16% of our total revenue was derived from these
occupational medicine services in fiscal year 2005, while 18% was derived in
both fiscal years 2004 and 2003.

Patient encounters were 553,000 in fiscal year 2005, 506,000 in fiscal year
2004, and 469,000 in fiscal year 2003. The increase in the number of patient
visits was mainly a result of an intense advertising campaign throughout South
Carolina, an increase in provided services, the opening of four new centers, and
continued successful efforts at enhanced customer service and patient
satisfaction.

No new significant competition entered our market during fiscal years 2005,
2004, and 2003.

The increase in the operating margin in 2005 of approximately 33% was largely
the result of increased revenues. The increase in the operating margin during
fiscal year 2004 was also due to increased revenues.



<PAGE>


The following table breaks out our revenue and patient visits by revenue source
for fiscal years 2005, 2004, and 2003.
<TABLE>
<S>     <C>                                             <C>      <C>    <C>           <C>    <C>       <C>

                                                              Percent of                    Percent of
                                                            Patient Visits                    Revenue
                                                         ---------------------        ------------------------
                                                          2005   2004   2003           2005   2004     2003
                                                         ------- ------ ------        ------- ------ ---------
                                                             16     18     16             11     12        11
        Patient Pay
                                                              9      9     10              4      5         5
        Employer Paid
                                                              6      8      8              7      9        10
        HMO
                                                             10     10     10             12     13        13
        Workers' Compensation
                                                             14     12     11             11      8         7
        Medicare/Medicaid
                                                             42     40     41             52     49        48
        Managed Care Insurance
                                                              3      3      4              3      4         6
        Other (Commercial Indemnity, Champus, etc.)
                                                         ------- ------ ------        ------- ------ ---------
                                                         ------- ------ ------        ------- ------ ---------
                                                            100    100    100            100    100       100
                                                         ======= ====== ======        ======= ====== =========
</TABLE>

As managed care plans attempt to cut costs, they typically increase the
administrative burden of providers by requiring referral approvals and by
requesting hard copies of medical records before they will pay claims. The
number of patients at our centers that are covered by a managed care plan versus
a traditional indemnity plan continues to grow. Management expects this trend to
continue.

Bad debt expense, a component of operating costs, was approximately $3,108,000
(or approximately 5% of revenue) for fiscal year 2005, $2,359,000 (or
approximately 5% of revenue) for fiscal year 2004, and $1,889,000 (or
approximately 4% of revenue) for fiscal year 2003. The collection percentage for
the established South Carolina centers has remained constant for the past 5
years.

General and administrative expenses include all salaries, benefits, supplies and
other operating expenses not specifically related to the day-to-day operations
of the centers. General and administrative expenses increased to $7,791,000 in
fiscal year 2005 as compared to $6,250,000 in fiscal year 2004. The increase is
primarily the result of advertising expense.

Depreciation and amortization expense increased slightly to $1,019,000 in fiscal
year 2005 as compared to $1,013,000 in fiscal year 2004. Net interest expense
decreased to $549,000 in fiscal year 2005 down from $693,000 in fiscal year
2004. This decrease was the result of more favorable terms and a lower interest
rate under the new loan agreement.

We evaluate the valuation allowance regarding deferred tax assets on a more
likely than not basis. In determining that it was more likely than not that the
recorded deferred tax asset would be realized, our management considered the
following:

o        Recent historical operating results.

o The budgets and forecasts that management and the Board of Directors have
adopted.

o The ability to utilize net operating losses NOLs prior to their expiration.

o The potential limitation of NOL utilization in the event of a change in
ownership.

o The generation of future taxable income in excess of income reported on the
consolidated financial statements.



<PAGE>


Deferred tax assets and liabilities are recorded based on the difference between
the financial statement and tax bases of assets and liabilities as measured by
the enacted tax rates which are anticipated to be in effect when these
differences reverse. The deferred tax provision is the result of the net change
in the deferred tax assets to amounts expected to be realized. Valuation
allowances are provided against deferred tax assets when the Company determines
it is more likely than not that the deferred tax asset will not be realized.
During the quarter ended December 31, 2004, our management determined that it
was more likely than not that the recorded deferred tax asset was realizable.
Therefore, we recorded an adjustment of approximately $4,500,000 based upon our
current financial position and results from operations, and our forecast of the
next twelve months. During the year ended September 30, 2005, the Company
recorded income tax expense of approximately $1,931,000.

Results of Operations for the Three Months Ended September 30, 2005 as Compared
to the Three Months Ended September 30, 2004:

Revenues of $14,786,000 for the quarter ending September 30, 2005 reflect an
increase of approximately 24 percent from those of the quarter ending September
30, 2004. The increase is attributed to an increase in the number of patient
visits and improved revenue per patient.

Patient encounters increased to 139,000 in the fourth quarter of fiscal year
2005 from 130,000 in the fourth quarter of fiscal year 2004.

The nineteen percent increase in operating costs reflects routine salary
adjustments and increases in advertising costs.

The decrease in net interest expense was the result of more favorable terms
under the new BB&T Loan Agreement. Financial Condition at September 30, 2005 and
September 30, 2004

Cash and cash equivalents increased by approximately $428,000 from September 30,
2004 to September 30, 2005.

Accounts receivable increased from $7,383,000 at September 30, 2004 to
$8,778,000 at September 30, 2005. This increase was attributable to the increase
in revenues during fiscal year 2005.

The increase in property and equipment is the result of medical equipment
purchases and facility renovations of approximately $2,191,000.

Long term debt increased from $3,504,000 at September 30, 2004 to $4,758,000 at
September 30, 2005. On June 16, 2005, we entered into a loan agreement with
Branch Banking & Trust Company of South Carolina in the principal amount of
$4,300,000 to refinance an existing term loan at more favorable terms and a
lower interest rate in order to pay the balance in full for all pre-petition
taxes due to the Internal Revenue Service and the South Carolina Department of
Revenue. The new variable interest rate is Branch Banking & Trust Company of
South Carolina's prime interest rate plus half a percent per annum and is
repayable monthly, with the final payment due on June 16, 2009.

Liquidity and Capital Resources

We require capital principally to fund growth (acquire new Centers), for working
capital needs, and for the retirement of indebtedness. We fund our capital
requirements and working capital needs through a combination of external
financing and credit extended by suppliers.

As of September 30, 2005, we have no material commitments for capital
expenditures or for acquisitions or start-ups.

Operating activities produced approximately $3,414,000 of cash during the fiscal
year 2005, compared with approximately $3,749,000 during the fiscal year 2004.
This decrease was the result of an increase in accounts receivable, which was
due to increased patient encounters.

Investing activities used $2,191,000 of cash during fiscal year 2005 and
1,833,000 of cash during fiscal year 2004. This increase is due to purchases of
equipment and building renovations for our operating sites.

Financing activities utilized approximately $794,000 in cash during the fiscal
year 2005 as compared to approximately $2,065,000 in cash during the fiscal year
2004. This decrease is primarily the result of increased borrowings under the
loan agreement offset by regular principal payments.

Overall, our current assets exceed our current liabilities at September 30, 2005
by $6,690,000 or a current ratio of 2.29.

Contractual Obligations

The following table summarizes our contractual obligations as of September 30,
2005:
<TABLE>
<S>                            <C>                 <C>                 <C>                <C>               <C>
                                                                  Payment Due By Period

Contractual Obligations            Total             < 1 Year          1-3 Years          3-5 Years          > 5 Years


Long-term Debt                     $ 4,662,890        $ 1,164,100        $1,867,631        $ 1,631,159           --
Capital Lease                           95,215             95,215          --                 --                 --
Operating Lease                     34,475,029          2,956,417         5,836,323          5,020,215       $20,662,074
</TABLE>

Please refer to the financial statement Footnotes No. 9 and 12.

Risk Factors
-------------

This Form 10-K contains forward-looking statements that involve risks and
uncertainties. Our actual results could differ materially than those anticipated
in these forward-looking statements as a result of factors both in and out of
our control, including the risks faced by us described below and elsewhere in
this Form 10-K. You should carefully read the risks described below. The risks
described below are not the only risks facing us. We have only described the
risks we consider to be the most material. There may be additional risks that
are viewed by us as not material or that are not presently known to us.

Risks Related to UCI Medical Affiliates, Inc.
----------------------------------------------


      We can provide no assurance that our medical centers will be able to
      compete effectively with other existing healthcare providers.

The business of providing healthcare-related services is highly competitive.
Many companies, including professionally managed physician practice management
companies like us, have been organized to acquire medical clinics, manage the
clinics, and employ clinic physicians at the clinics. Large hospitals, other
physician practice centers, private doctor's offices and healthcare companies,
HMOs, and insurance companies are also involved in activities similar to ours.
Because our main business is the provision of medical services to the general
public, our primary competitors are the local physician practices and hospital
emergency rooms in the markets where we own medical centers. Some of these
competitors have longer operating histories and significantly greater resources
than we do. In addition, these traditional sources of medical services, such as
hospital emergency rooms and private physicians, have had in the past a higher
degree of recognition and acceptance than the medical centers that we operate.
We cannot assure you that we will be able to compete effectively or that
additional competitors will not enter the market in the future.

      If a regulatory authority finds that our organization and relationships do
      not comply with existing or future laws and regulations, our operations
      could be materially adversely affected.

As a participant in the healthcare industry, our operations and relationships
are subject to extensive and increasing regulation by a number of governmental
bodies at the federal, state and local levels. Although we have tried to
structure our business to comply with these existing laws and regulations, we
have had little guidance as to whether we comply or not because of the unique
structure of our business operations. We cannot assure you that a review by the
courts or regulatory authorities of our former or current business will not
result in a determination that could adversely affect our operations. In
particular, we can provide you with no assurance that a court or regulatory body
would find that our structure and business operations comply with the following:

     o State and federal  laws  limiting the  provision  of medical  services by
business corporations;
     o    State and federal anti-kickback and self-referral laws;

     o    Antitrust laws; and

     o    Federal and state laws and regulations governing insurance companies,
          HMOs, and other managed care organizations.

We have provided you with a discussion of each of these areas in the section
titled "Government Regulation" under Item 1 above. Furthermore, the laws and
regulations governing the healthcare industry change rapidly and constantly. In
the future, the regulatory environment may change in a manner as to require us
to modify or restrict our existing operations and any proposed expansion of our
business. Restrictions on or modifications of our operations because of a
changing regulatory environment could materially adversely affect our business.

      If the laws, regulations, and policies governing government-sponsored
      healthcare programs are changed, our operations could be materially
      adversely affected.

Historically, we derive approximately eleven percent of our revenues from
payments made by government-sponsored healthcare programs (principally, Medicare
and Medicaid). As a result, any change in the laws, regulations, or policies
governing reimbursements could adversely affect our operations. Additionally,
state and federal civil and criminal statutes impose substantial penalties,
including civil and criminal fines and imprisonment, on healthcare providers
that fraudulently or wrongfully bill governmental or other third-party payors
for healthcare services. We believe we are in material compliance with these
laws, but we cannot assure you that our activities will not be challenged or
scrutinized by governmental authorities.

      Departures of our key personnel or directors will impair our operations.

     We have the following  executive  officers:  D. Michael  Stout,  M.D.,  our
President, Chief Executive Officer and Director of Medical Affairs; and Jerry F.
Wells,  Jr., CPA, our Executive Vice  President,  Chief Financial  Officer,  and
Corporate  Secretary.  They are instrumental in our organization and are the key
management  officials in charge of our daily business  operations.  We cannot be
assured of the  continued  service of either of them,  and each of them would be
difficult  to  replace.  Additionally,  our  directors'  community  involvement,
diverse backgrounds,  and extensive business  relationships are important to our
success.

      Because of the nature of our business, we run the risk that we will be
unable to collect the fees that we have earned. Virtually all of our
consolidated net revenue was derived in the past, and we believe will be derived
in the future, from our medical centers' charges for services on a
fee-for-service basis. Accordingly, we assume the financial risk related to
collection, including the potential uncollectability of accounts, long
collection cycles for accounts receivable, and delays attendant to reimbursement
by third party payors, such as governmental programs, private insurance plans
and managed care organizations. Increases in write-offs of doubtful accounts,
delays in receiving payments or potential retroactive adjustments, and penalties
resulting from audits by payors may require us to borrow funds to meet our
current obligations or may otherwise have a material adverse effect on our
financial condition and results of operations.

      We are subject to certain special risks in connection with the intangible
assets reported on our balance sheet. As a result of our various acquisition
transactions, intangible assets (net of accumulated amortization) of
approximately $3.4 million have been recorded on our balance sheet as of
September 30, 2005. Because of a change in accounting principles adopted by the
accounting profession, we ceased amortizing our intangible assets in the fiscal
year ending September 30, 2002. Instead, after an initial review of our
intangible assets for impairment in connection with our adoption of this new
accounting principle, we analyze our intangible assets on an annual basis for
impairment of value.

Under these current accounting standards, our net unamortized balance of
intangible assets acquired was not considered to be impaired as of September 30,
2005. In the past, however, we have recorded impairments to our intangible
assets when appropriate. For example, effective September 30, 2001, we recorded
impairment in the approximate amount of $750,000 to reduce our intangible assets
to fair value. We recorded this impairment because we combined two of our
Knoxville, Tennessee locations, and we also had decreased profitability in a
Columbia and Greenville center. Therefore, we deemed that the goodwill
associated with these three locations was impaired and should be written off.

We cannot assure you that we will ever realize the value of our remaining
intangible assets in the future. We may be required to recognize that the value
of our intangible assets has been further impaired in our subsequent annual
reviews upon analyzing our operating results. Any future determination that a
significant impairment has occurred would require us to write-off the impaired
portion of our remaining intangible assets, which could have a material adverse
effect on our results of operations.

      Our business is concentrated in specific geographic locations and could be
affected by a depressed economy in these areas.

We provide our services to areas in South Carolina and Tennessee. A stagnant or
depressed economy in these states could affect all of our markets and adversely
affect our business and results of operations.

      Terrorist attacks, such as the attacks that occurred in New York and
      Washington, D.C. on September 11, 2001, and other attacks, acts of war, or
      military actions, such as continued military actions in Iraq or elsewhere,
      may adversely affect our operating results and financial condition.

The attacks of September 11, 2001 have contributed to major instability in the
U.S. and other financial markets. These terrorist attacks, the military
response, and other future developments, may adversely affect prevailing
economic conditions. These developments, depending on their magnitude, could
have a material adverse effect on our operating results and financial condition.

Risks Related to Our Common Stock

      You may have difficulty in selling your shares because of the absence of
an active public market.
On October 20, 1998, our common stock was delisted for trading on the NASDAQ
SmallCap Market. Shortly before our delisting, NASDAQ raised its criteria to
remain listed on the NASDAQ SmallCap Market. Our delisting was a consequence of
our failure to meet the increased requirements for the value of assets for
companies traded on the NASDAQ SmallCap Market.

Because our stock is no longer listed on the NASDAQ SmallCap Market, trading in
our common stock is conducted in the over-the-counter market. Consequently, our
stockholders have found disposing of shares of our common stock and obtaining
accurate quotations of its market value more difficult. In addition, the
delisting makes our common stock substantially less attractive as:
     o    collateral for loans;

     o an  investment  by  financial  institutions  because  of  their  internal
policies or state legal investment laws;

     o consideration  to finance any future  acquisitions of medical  practices;
and,

     o an investment opportunity by investors should we desire to raise
additional capital in the future. Although our common stock is currently
eligible for quotation on the over-the-counter bulletin board, we have been
informed that the NASD may be considering higher standards for permitting
quotations of securities on the bulletin board. If the NASD does raise its
standards, the over-the-counter bulletin board may no longer be available as a
trading market for our stockholders as well. Consequently, potential investors
should only invest in our common stock if they have a long-term investment
intent. If an active market does not develop and a shareholder desires to sell
its shares of our common stock, the shareholder will be required to locate a
buyer on its own and may not be able to do so.

      The absence of a public market makes the price of our common stock
      particularly volatile and susceptible to market fluctuations.

Trading in our common stock has historically been very limited, and we cannot
assure you that an active trading market for our common stock will ever develop
or be sustained. Because of the limited trading liquidity in our common stock,
the market price of our common stock has been vulnerable to significant
fluctuations in response to very limited market trading in our shares. Sales of
substantial amounts of our common stock, or the availability of substantial
amounts of our common stock for future sale, could adversely affect the
prevailing market price of our common stock. The market price of our common
stock will remain subject to significant fluctuations in response to these
factors as well as in response to operating results and other factors affecting
stock prices generally. The stock market in recent years has experienced price
and volume fluctuations that often have been unrelated or disproportionate to
the operating performance of companies. These fluctuations, as well as general
economic and market conditions, may adversely affect the market price of our
common stock in the future.

      Shareholders may have difficulty selling their shares because our common
      stock is a "penny stock" and is subject to special SEC rules that make
      transactions in our common stock burdensome for broker-dealers.

As long as the trading price of our common stock is less than $5.00 per share,
our common stock will be considered to be a "penny stock" under SEC rules.
Generally, a "penny stock" is any non-NASDAQ equity security that has a market
price of less than $5.00 per share. If a penny stock is traded in the secondary
market, these SEC rules require the broker-dealer to provide to the purchaser a
disclosure schedule explaining the penny stock market and the risks associated
with it. These SEC rules also require broker-dealers to abide by various sales
practices if they sell penny stocks to persons other than established customers
and accredited investors. For these penny stock transactions, the broker-dealer
must make a special determination that the investment in the penny stock is
suitable for the purchaser and receive the purchaser's written consent to the
purchase before the transaction. The additional burdens that these SEC rules
impose upon broker-dealers may discourage broker-dealers from effecting
transactions in our common stock and could severely limit a shareholder's
ability to sell its shares in the secondary market.

      The market price of our common stock may fluctuate widely in the future.
The trading price of our common stock could be subject to wide fluctuations in
response to quarter-to-quarter variations in our operating results, material
announcements made by us from time to time, governmental regulatory action,
general conditions in the healthcare industry, or other events, or factors, many
of which are beyond our control. In addition, the stock market has experienced
extreme price and volume fluctuations, which have particularly affected the
market prices of many healthcare services companies and which have often been
unrelated to the operating performance of these companies. Our operating results
in future quarters may be below the expectations of securities analysts and
investors. In this event, the price of our common stock would likely decline,
perhaps substantially.

      The market price of our common stock may decline should a substantial
      number of shares of our common stock be offered for sale on the open
      market.

Sales of substantial amounts of our common stock in the public market, or the
perception that these sales could occur, could adversely affect prevailing
market prices of our common stock and could impair our future ability to raise
capital through the sale of our equity securities. We are unable to predict the
effect, if any, that future sales of our common stock or the availability of our
common stock for sale may have on the market price of our common stock
prevailing from time to time.

      Anti-takeover provisions in our certificate of incorporation and state
      corporate laws could deter or prevent take-over attempts by a potential
      purchaser of our common stock and deprive you of the opportunity to obtain
      a takeover premium for your shares.

In many cases, stockholders receive a premium for their shares when a company is
purchased by another. Various provisions in our certificate of incorporation and
bylaws and state corporate laws could deter and make it more difficult for a
third party to bring about a merger, sale of control, or similar transaction
without approval of our board of directors. These provisions tend to perpetuate
existing management. As a result, our shareholders may be deprived of
opportunities to sell some or all of their shares at prices that represent a
premium over market prices.


<PAGE>


These provisions, which could make it less likely that a change in control will
occur, include:
          provisions in our certificate of incorporation establishing three
     classes of directors with staggered o terms, which means that only
     one-third of the members of the board of directors is elected each year and
          each director serves for a term of three years.

          provisions in our certificate of incorporation authorizing the board
          of directors to issue a series of preferred stock without shareholder
          action, which issuance could discourage a third party from
     o    attempting to acquire, or make it more difficult for a third party to
          acquire, a controlling interest in us.

      We do not expect to pay dividends on our common stock in the foreseeable
future.
We have no source of income other than dividends that we receive from our
operating subsidiary, UCI-SC. Our ability to pay dividends to shareholders will
therefore depend on the subsidiary's ability to pay dividends to us. The
subsidiary intends to retain future earnings, if any, for use in the operation
and expansion of our business. Consequently, we do not plan to pay dividends
until we recover any losses that we have incurred and become profitable.
Additionally, our future dividend policy will depend on our earnings, financial
condition and other factors that our Board of Directors considers relevant.

      Shareholders may suffer dilution in their interests in our common stock if
      we offer additional shares of common stock in the future or if certain
      third parties exercise their option rights to acquire additional shares of
      our common stock.

There is no present intent to offer for sale additional shares of common stock.
However, we cannot ensure that, in the future, we will not have to seek
additional capital by offering and selling additional shares of common stock in
order to continue to operate, acquire additional medical practices in our
current or other markets, or achieve successful operations. If it becomes
necessary to raise additional capital to support our operations, there is no
assurance that additional capital will be available to us, that additional
capital can be obtained on terms favorable to us, or that the price of any
additional shares that may be offered by us in the future will not be less than
the subscription price paid by our shareholders. The effect on existing
stockholders of sales of additional shares of common stock cannot presently be
determined.

As of September 30, 2005, BlueChoice HealthPlan "BCHP" [formerly known as
Companion HealthCare Corporation `CHC'], a wholly-owned subsidiary of BCBS,
owned in the aggregate 6,726,019 shares, or approximately 69.05 percent, of our
outstanding common stock. Under various agreements among BCHP and us, we have
given these companies the right at any time to purchase from us the number of
shares of our voting stock as is necessary for BCBS and its affiliated entity,
as a group, to obtain and then maintain an aggregate ownership of 48 percent of
our outstanding voting stock. To the extent the BCBS subsidiary exercises its
right in conjunction with a sale of voting stock by us, the price to be paid by
the BCBS subsidiary is the average price to be paid by the other purchasers in
that sale. Otherwise, the price is the average closing bid price of our voting
stock on the ten trading days immediately preceding the election by the BCBS
subsidiary to exercise its purchase rights. Consequently, to the extent the BCBS
subsidiary elects to exercise any or a portion of its rights under these
anti-dilution agreements, the sale of shares of common stock to the BCBS
subsidiary will have the effect of further reducing the percentage voting
interest in us represented by a share of the common stock.

         Certain affiliates have the ability to exercise substantial influence.

The substantial ownership of our common stock by the BCBS subsidiary and other
of our affiliates may provide them with the ability to exercise substantial
influence in the election of directors and other matters submitted for approval
by our stockholders. As a result, other stockholders may be unable to
successfully oppose matters that are presented by these entities for action by
stockholders, or to take actions that are opposed by these entities. The
ownership by these entities may also have the effect of delaying, deterring, or
preventing a change in our control without the consent of these entities. These
effects could reduce the value of our stock. In addition, sales of common stock
by these entities could result in another stockholder obtaining control over us.

Item 7A.  Quantitative and Qualitative Disclosures About Market Risk

We are exposed to changes in interest rates primarily as a result of our
borrowing activities, which includes credit facilities with financial
institutions used to maintain liquidity and fund our business operations, as
well as notes payable to various third parties in connection with certain
acquisitions of property and equipment. The nature and amount of our debt may
vary as a result of future business requirements, market conditions and other
factors. The definitive extent of our interest rate risk is not quantifiable or
predictable because of the variability of future interest rates and business
financing requirements. We do not currently use derivative instruments to adjust
our interest rate risk profile.

Approximately $572,000 of our debt at September 30, 2005 was subject to fixed
interest rates. Approximately $4,186,000 of our debt at September 30, 2005 was
subject to variable interest rates. Based on the outstanding amounts of variable
rate debt at September 30, 2005, our interest expense on an annualized basis
would increase approximately $42,000 for each increase of one percent in the
prime rate.

We do not utilize financial instruments for trading or other speculative
purposes, nor do we utilize leveraged financial instruments.

Item 8.  Financial Statements and Supplementary Data

Reference is made to the Index to Financial Statements on Page 36.

     Item 9. Changes in and  Disagreements  with  Accountants  on Accounting and
Financial Disclosure

None.

Item 9A.  Controls and Procedures

We conducted an evaluation of the effectiveness of the design and operation of
our "disclosure controls and procedures" (Disclosure Controls) as of the end of
the period covered by this Annual Report. The controls evaluation was done under
the supervision and with the participation of management, including our Chief
Executive Officer (CEO) and Chief Financial Officer (CFO).

Attached as exhibits to this Annual Report are certifications of the CEO and the
CFO, which are required in accordance with Rule 13a-15(e) of the Exchange Act.
This Controls and Procedures section includes the information concerning the
controls evaluation referred to in the certifications and it should be read in
conjunction with the certifications for a more complete understanding of the
topics presented.

Definition of Disclosure Controls

Disclosure Controls are controls and procedures designed to reasonably assure
that information required to be disclosed in our reports filed under the
Exchange Act, such as this Annual Report, is recorded, processed, summarized and
reported within the time periods specified in the SEC's rules and forms.
Disclosure Controls are also designed to reasonably assure that such information
is accumulated and communicated to our management, including the CEO and CFO, as
appropriate to allow timely decisions regarding required disclosure. Our
Disclosure Controls include components of our internal control over financial
reporting, which consists of control processes designed to provide reasonable
assurance regarding the reliability of our financial reporting and the
preparation of financial statements in accordance with US generally accepted
accounting principles. To the extent that components of our internal control
over financial reporting are included within our Disclosure Controls, they are
included in the scope of our annual controls evaluation.

Limitations on the Effectiveness of Controls

The company's management, including the CEO and CFO, does not expect that our
Disclosure Controls or our internal control over financial reporting will
prevent all error and all fraud. A control system, no matter how well designed
and operated, can provide only reasonable, not absolute, assurance that the
control system's objectives will be met. Further, the design of a control system
must reflect the fact that there are resource constraints, and the benefits of
controls must be considered relative to their costs. Because of the inherent
limitations in all control systems, no evaluation of controls can provide
absolute assurance that all control issues and instances of fraud, if any,
within the company have been detected. These inherent limitations include the
realities that judgments in decision-making can be faulty, and that breakdowns
can occur because of simple error or mistake. Controls can also be circumvented
by the individual acts of some persons, by collusion of two or more people, or
by management override of the controls. The design of any system of controls is
based in part upon certain assumptions about the likelihood of future events,
and there can be no assurance that any design will succeed in achieving its
stated goals under all potential future conditions. Over time, controls may
become inadequate because of changes in conditions or deterioration in the
degree of compliance with policies or procedures. Because of the inherent
limitations in a cost-effective control system, misstatements due to error or
fraud may occur and not be detected.

Scope of the Controls Evaluation

The evaluation of our Disclosure Controls included a review of the controls'
objectives and design, the company's implementation of the controls and the
effect of the controls on the information generated for use in this Annual
Report. In the course of the controls evaluation, we sought to identify data
errors, controls problems or acts of fraud and confirm that appropriate
corrective action, including process improvements, were being undertaken. This
type of evaluation is performed on a quarterly basis so that the conclusions of
management, including the CEO and CFO, concerning controls effectiveness can be
reported in our Quarterly Reports on Form 10-Q and to supplement our disclosures
made in our Annual Report on Form 10-K. Many of the components of our Disclosure
Controls are also evaluated on an ongoing basis by our Internal Audit Department
and by other personnel in our Finance organization, as well as our independent
auditors who evaluate them in connection with determining their auditing
procedures related to their report on our annual financial statements and not to
provide assurance on our controls. The overall goals of these various evaluation
activities are to monitor our Disclosure Controls, and to modify them as
necessary; our intent is to maintain the Disclosure Controls as dynamic systems
that change as conditions warrant.

Among other matters, we also considered whether our evaluation identified any
"significant deficiencies" or "material weaknesses" in our internal control over
financial reporting, and whether the company had identified any acts of fraud
involving personnel with a significant role in our internal control over
financial reporting. This information was important both for the controls
evaluation generally, and because item 5 in the certifications of the CEO and
CFO require that the CEO and CFO disclose that information to our Board's Audit
Committee and to our independent auditors. In the professional auditing
literature, "significant deficiencies" are referred to as "reportable
conditions," which are deficiencies in the design or operation of controls that
could adversely affect our ability to record, process, summarize and report
financial data in the financial statements. Auditing standards define "material
weakness" as a particularly serious reportable condition where the internal
control does not reduce to a relatively low level the risk that misstatements
caused by error or fraud may occur in amounts that would be material in relation
to the financial statements and the risk that such misstatements would not be
detected within a timely period by employees in the normal course of performing
their assigned functions. We also sought to address other control matters in the
controls evaluation, and in each case if a problem was identified, we considered
what revision, improvement and/or correction to make in accordance with our
ongoing procedures.

Conclusions

Based upon the controls evaluation, our CEO and CFO have concluded that, subject
to the limitations noted above, as of the end of the period covered by this
Annual Report, our Disclosure Controls were effective to provide reasonable
assurance that material information relating to UCI and its consolidated
subsidiaries is made known to management, including the CEO and CFO,
particularly during the period when our periodic reports are being prepared.

Item 9B.  Other Information

None.






<PAGE>




                                    PART III



Item 10.   Directors and Executive Officers of the Registrant

Directors

Our Certificate of Incorporation provides for a classified Board of Directors so
that, as nearly as possible, one-third of the members of the Board are elected
at each annual meeting to serve until the third annual stockholders' meeting
after their election.

Directors Whose Terms Expire at the Annual Meeting Expected to be Held in 2008:

     Joseph A. Boyle,  CPA, 51, has served as the President and Chief  Executive
Officer  of  Affinity  Technology  Group,  Inc.  since  January  2000 and as its
Chairman since March 2001. Mr. Boyle served as Affinity's  Senior Vice President
and Chief  Financial  Officer  from  September  1996 until  January  2000 and as
Chairman and Chief Executive  Officer of Surety  Mortgage,  Inc., a wholly owned
subsidiary of Affinity,  from December 1997 until  December 2001. Mr. Boyle is a
certified public accountant and since January 2005 has served as Chief Operating
Officer of Community  Resource  Mortgage,  Inc., a wholly  owned  subsidiary  of
Community  Bancshares,  Inc.  From April 2003 to August  2004,  Mr.  Boyle was a
partner in the  accounting  firm of  Elliott  Davis,  LLC.  From June 1982 until
August 1996, Mr. Boyle was employed by Price Waterhouse, LLP and from 1993 until
1996 was a partner in its Kansas City,  Missouri  office where he specialized in
the financial  services  industry.  Mr. Boyle was most  recently  reelected as a
director at the annual meeting of stockholders in 2005.

     Ashby M. Jordan,  M.D., 65, has served as one of our directors since August
1996 and as Vice President of Medical Affairs of Blue Cross Blue Shield of South
Carolina since  December 1986.  Prior to joining Blue Cross Blue Shield of South
Carolina,  Dr.  Jordan  was the Vice  President  of  Medical  Affairs  for CIGNA
HealthPlan of South Florida,  Inc. Dr. Jordan is Board Certified by the American
Board of Pediatrics. Dr. Jordan was most recently reelected as a director at the
annual meeting of stockholders in 2005

     John M. Little,  Jr.,  M.D.,  MBA,  54, has served as one of our  directors
since August 1998 and is currently the Vice  President for  HealthCare  Services
and Chief  Medical  Officer  for Blue Cross Blue Shield of South  Carolina.  Dr.
Little also  served in the same  position at  BlueChoice  Health Plan  (formerly
known as Companion  HealthCare  Corporation) from 1994 to 2000. Prior to joining
BlueChoice Health Plan (formerly known as Companion  HealthCare  Corporation) in
1994, Dr. Little served as Assistant  Chairman for Academic Affairs,  Department
of Family Practice,  Carolinas  Medical Center,  Charlotte,  North Carolina from
1992 to 1994. Dr. Little was most recently reelected as a director at the annual
meeting of stockholders in 2005.

Directors Whose Terms Expire at the Annual Meeting Expected to be Held in 2007:

Jean E. Duke, CPA, 50, has owned a consulting business since December 2004
providing services primarily for insurance and financial organizations. Prior to
that, Ms. Duke was affiliated with Colonial Life & Accident Insurance Company,
serving in the roles of Senior Vice President, Customer & Information Services,
and President & Chief Financial Officer, from August 2002 to December 2004. Ms.
Duke is a certified public accountant. A graduate of Leadership Columbia, she
was named the Financial Executive of the Year by the Columbia chapter of the
Institute of Management Accountants, the Distinguished Young Alumni by the Moore
School of Business, and was honored with the Tribute to Women and Industry award
by the Young Women's Christian Association. Ms. Duke has held leadership and
board positions with many professional and business organizations as well as
continuing to be active in numerous community organizations. Ms. Duke was
elected as a director at the annual meeting of stockholders in 2004. Timothy L.
Vaughn, CPA, 40, has served as Chief Financial Officer of BlueChoice Health Plan
(formerly known as Companion HealthCare Corporation) since January 2000. He
served as TRICARE Contracts Manager for Blue Cross Blue Shield of South Carolina
from 1997 to 2000. This federal program provided health benefits administration
for military dependents and retirees across the nation. Mr. Vaughn is a
certified public accountant and has been named a Fellow in both the Academy of
Healthcare Management and Life Management Institute and is currently serving as
Corporate Secretary and Treasurer of EAP Alliance, Inc. in Columbia, South
Carolina. He is a member of numerous professional and civic organizations. Mr.
Vaughn was most recently elected as a director at the annual meeting of
stockholders in 2004.

Directors Whose Terms Expire at the Annual Meeting Expected to be Held in 2006:

Harold H. Adams, Jr., 58, has served as one of our directors since June 1994 and
as Chairman and owner of Adams and Associates International and Southern
Insurance Managers since June 1992. He served as President of Adams Eaddy and
Associates, an independent insurance agency, from 1980 to 1992. Mr. Adams has
been awarded the Chartered Property Casualty Underwriter designation and is
currently a member of the President's Board of Visitors of Charleston Southern
University in Charleston, South Carolina. He has received numerous professional
awards as the result of over 34 years of involvement in the insurance industry
and is a member of many professional and civic organizations. Mr. Adams was most
recently reelected as a director at the annual meeting of stockholders in 2003.


Charles M. Potok, 56, has served as our Chairman of the Board since February
2003, and has served as one of our directors since September 1995. He has served
as Executive Vice President and Chief Operating Officer of Companion Property
and Casualty Company, a wholly-owned subsidiary of Blue Cross Blue Shield of
South Carolina, since March 1984 and, as President of Companion Property and
Casualty Company since April 2002. Mr. Potok is an Associate of the Casualty
Actuarial Society and a member of the American Academy of Actuaries. Prior to
joining Companion Property and Casualty Company, Mr. Potok served as Chief
Property and Casualty Actuary and Director of the Property and Casualty Division
of the South Carolina Department of Insurance. Mr. Potok was most recently
reelected as a director at the annual meeting of stockholders in 2003.

 Executive Officers

The following sets forth certain information concerning our executive officers
of UCI.

D. Michael Stout, M.D., 60, has served as Executive Vice President of Medical
Affairs of UCI and Doctors Care, P.A. ("DC-SC") since 1985 and as President and
Chief Executive Officer of UCI, UCI-SC, DC-SC and Doctors Care of Tennessee,
P.C. since November 1, 2002, and of COSM since April 5, 2005. He is Board
Certified in Emergency Medicine and is a member of the American College of
Emergency Physicians, the Columbia Medical Society, and the American College of
Physician Executives. He graduated from Brown University Medical School in 1980
and practiced medicine for Doctors Care since 1983. Recently, he was elected as
a member of the Board of Directors of the South Carolina Campaign to Prevent
Teen Pregnancy.

Jerry F. Wells, Jr., CPA, 43, has served as our Executive Vice President and
Chief Financial Officer since he joined us in February 1995 and as our Corporate
Secretary since December 1996. He has served as Executive Vice President of
Finance, Chief Financial Officer and Corporate Secretary of UCI-SC since
December 1996, the Corporate Secretary of DC-SC since December 1996, and the
Corporate Secretary of COSM and PPT since April 5, 2005. Prior to joining us, he
served as a Senior Manager and consultant for PricewaterhouseCoopers LLP from
1985 until February 1995. Mr. Wells is a certified public accountant and is a
member of the American Institute of Certified Public Accountants, the South
Carolina Association of Certified Public Accountants, and the North Carolina CPA
Association.



<PAGE>


Board of Directors and Board Committees

Board of Directors

The Board of Directors held a total of four meetings during our fiscal year
ended September 30, 2005. No director attended fewer than 75 percent of the
aggregate of: (1) the total of these Board meetings; and (2) the total number of
meetings of the committees upon which the director served. Among the standing
committees established by the Board of Directors are a Compensation Committee,
an Audit Committee, and a Nominating Committee. All current directors, other
than Ashby M. Jordan, M.D., Harold H. Adams, Jr., and Timothy L. Vaughn, CPA,
attended our 2005 annual stockholder meeting. We expect our directors to
dedicate sufficient time, energy, and attention to ensure the diligent
performance of their duties, including attending our stockholder meetings and
the meetings of the Board and its Committees on which they serve.

Audit Committee

We describe the functions of the Audit Committee under the heading "Report of
the Audit Committee" in this Form 10-K on page 34. The Audit Committee operates
under a written Charter. All of the members of the Audit Committee are
independent within the meaning of SEC regulations. The Board of Directors has
determined that Mr. Boyle and Ms. Duke are financial experts, as that term is
defined in Item 401(h)(2) of Regulation S-K under the Exchange Act. The Audit
Committee met four times during the fiscal year ended September 30, 2005 and
consisted of Mr. Adams, Ms. Duke and Mr. Boyle, with Mr. Boyle acting as
Chairman.

Compensation Committee

During our fiscal year ended September 30, 2005, the Compensation Committee
consisted of Dr. Little, Dr. Jordan, Mr. Vaughn, and Mr. Potok, with Mr. Potok
acting as Chairman. This committee monitors our executive compensation plan,
practice and policies, including all salaries, bonus awards, and fringe
benefits, and makes recommendations to the Board of Directors with respect to
changes in existing executive compensation plans and the formation and adoption
of new executive compensation plans. This committee met one time during our
fiscal year ended September 30, 2005. The report of the Compensation Committee
appears in this Form 10-K on page 29.

Nominating Committee

The Nominating Committee makes recommendations to the Board with respect to the
size and composition of the Board, reviews the qualifications of potential
candidates for election as director, and recommends director nominees to the
Board. All of the members of the Nominating Committee are independent within the
meaning of SEC regulations. The Nominating Committee operates under a written
Charter. The Nominating Committee met one time during the fiscal year ended
September 30, 2005 and consisted of Mr. Adams, Ms. Duke, and Mr. Boyle, with Mr.
Adams acting as Chairman.

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the 1934 Act requires the directors, officers, and beneficial
owners of more than ten percent of a registrant's common stock to file reports
of holdings and acquisitions in common stock with the Securities and Exchange
Commission. To our knowledge, based solely upon a review of such reports
furnished to us, and written representations that no other reports were
required, we believe that all of our directors and officers complied during our
fiscal year ended September 30, 2005 with the filing requirements under Section
16(a) of the 1934 Act.

Code of Ethics

We adopted a Code of Ethics that applies to our principal executive officer,
principal financial officer, principal accounting officer or controller, or
persons performing similar functions. We filed a copy of this code as Exhibit 14
to our annual report on Form 10-K for the fiscal year ended September 30, 2003.



<PAGE>


Item 11.   Executive Compensation

The following table summarizes for each of the indicated years the compensation
earned by each of our executive officers, as that term is defined by Securities
and Exchange Commission rules, whose annual compensation from us for all
services provided to us or our subsidiaries during any of the indicated years
exceeded $100,000.
<TABLE>
<S>                                <C>             <C>          <C>               <C>                 <C>

                                            Summary Compensation Table
                                                                                    Long Term
                                              Annual Compensation                  Compensation

                                                                                    Securities
                                                                                    Underlying          All Other
Name and Principal Position         Fiscal Year    Salary (1)    Bonus (1)           Options           Compensation
---------------------------         -----------    ----------    ---------           -------           ------------

D. Michael Stout, M.D.                  2005      $278,100                                  0                  0
                                     $94,000
President and                           2004        261,000          81,000                 0                  0
                                                  (2)
Chief Executive Officer                 2003        227,000          88,000                 0                  0
                                                  (2)

Jerry F. Wells, Jr., CPA                2005      $183,900                                  0                  0
                                     $70,000
Executive Vice President,               2004        166,100          59,000                 0                  0
Chief Financial Officer,                2003        144,500          39,000                 0                  0
 and Corporate Secretary
</TABLE>


(1)      Amounts included under the heading "Salary" and "Bonus" include
         compensation from both UCI-SC and DC-SC. The remuneration described in
         the table above does not include our cost of benefits furnished to
         certain officers that were extended in connection with the conduct of
         our business. The amount of such benefits accrued for each of the named
         executives in each of the years reflected in the table did not exceed
         10% of the total annual salary and bonus reported for such executive in
         such year.

(2)      For services performed by Dr. Stout for UCI-SC, Dr. Stout received an
         annual salary of $50,000 in each of the three fiscal years ended
         September 30, 2005, 2004, and 2003. For services performed by Dr. Stout
         for DC-SC, Dr. Stout received an annual salary of $228,000, $211,000,
         and $177,000 in the fiscal years ended September 30, 2005, 2004 and
         2003. Dr. Stout has served as the President and Chief Executive Officer
         of UCI, UCI-SC, and DC-SC since November 1, 2002.

Fiscal Year End Option Values

The following table sets forth certain information with respect to unexercised
options to purchase our common stock held at September 30, 2005. None of the
named executive officers exercised any options during the fiscal year ended
September 30, 2005. Additionally, no options were granted to any officer or
director during the fiscal year ended September 30, 2005.

<TABLE>
<S>                                <C>                 <C>                     <C>                <C>

                                               2005 Fiscal Year End
                                                   Option Values
                                      Number of Securities Underlying                 Value of Unexercised
                                          Unexercised Options at                          In-the-Money
                                              Fiscal Year End                      Options at Fiscal Year End
                                 ------------------------------------------  ---------------------------------------
             Name                   Exercisable          Unexercisable          Exercisable        Unexercisable
---------------------------------------------------- ---------------------- -------------------- -------------------




                                      89,825                   0                     0                   0
D. Michael Stout, M.D.
President and
Chief Executive Officer


                                      109,825                  0                     0                   0
Jerry F. Wells, Jr., CPA
Executive    Vice    President,
Chief  Financial  Officer,  and
Corporate Secretary
</TABLE>


Director Compensation

Currently, members of our Board receive the following retainer fees: $6,000 per
fiscal year for the Chairman, $5,000 per year for Committee members, and $4,000
per year for all other members of the Board. We also reimburse directors for
out-of-pocket expenses reasonably incurred by them in the discharge of their
duties as directors of our company.

During the fiscal year ended September 30, 1996, we adopted a Non-Employee
Director Stock Option Plan (the "1996 Non-Employee Plan"). The 1996 Non-Employee
Plan provided for the granting of options to two non-employee directors for the
purchase of 10,000 shares of our common stock at the fair market value as of the
date of grant. Under this plan, we issued 5,000 options to Harold H. Adams, Jr.,
and 5,000 options to Russell J. Froneberger. These options are exercisable
during the period commencing on March 20, 1999 and ending on March 20, 2006. At
September 30, 2005, stock options for 5,000 shares were outstanding under the
1996 Non-Employee Plan, all of which were exercisable.

During the fiscal year ended September 30, 1997, we adopted a Non-Employee
Director Stock Option Plan (the "1997 Non-Employee Plan"). The 1997 Non-Employee
Plan provided for the granting of options to three non-employee directors for
the purchase of 20,000 shares of our common stock at the fair market value as of
the date of grant. Under this plan, we issued 5,000 options each to Thomas G.
Faulds, Ashby M. Jordan, M.D., and Charles M. Potok. These options are
exercisable during the period commencing on March 28, 2000 and ending on March
28, 2007. At September 30, 2005, stock options for 10,000 shares were
outstanding under the 1997 Non-Employee Plan, all of which were exercisable.

Employment Contracts

We have not entered into employment agreements with our Executive Officers.

Compensation Committee Interlocks and Insider Participation

None of the members of the Compensation Committee is or has been our executive
officer or employee or an executive officer or employee of any of our
subsidiaries. None of the members of the Compensation Committee is or has been a
member of the compensation committee of another entity. None of our executive
officers are or have been a member of the compensation committee, or a director,
of another entity.

Compensation Committee Report on Executive Compensation

The Compensation Committee of the Board of Directors generally determines the
compensation of our executive officers. This committee reviews and recommends to
the Board the salaries and other compensation of all of our officers and
directors. The Compensation Committee also administers our Stock Incentive
Plans. The following report is being furnished with respect to certain
compensation paid or awarded to our executive officers during the fiscal year
ended September 30, 2005.

General Policies. Our compensation program is intended to enable us to attract,
motivate, reward, and retain the management talent to achieve corporate
objectives and thereby increase shareholder value. Our policy is to provide
incentives to senior management to achieve both short-term and long-term
objectives. To attain these objectives, our executive compensation program is
composed of a base salary, incentive compensation and stock options.

Base Salary. Base salaries for Dr. Stout and Mr. Wells were determined by a
subjective assessment of the executive officer's performance, in light of the
officer's responsibilities and position with us and our performance during prior
periods. In evaluating our overall performance, the primary focus is on
financial performance for the relevant annual period measured by operating
income. The Committee also considers the recommendations of the Chief Executive
Officer (except in the case of his own compensation); to the extent available,
the salary norms for persons in comparable positions at comparable companies;
and the person's experience. The Committee reviews base salaries from time to
time and adjusts them appropriately.



<PAGE>


Incentive Compensation. The Compensation Committee determines cash bonuses for
all executive officers and awards the bonuses only if we, or any applicable
subsidiary or business unit, achieve performance objectives. We designed our
long-term incentive compensation for executive officers to focus management's
attention on our future. We provide long-term compensation through grants of
stock options. The number of stock options granted is based upon the executive's
salary, performance, and responsibilities. Each executive officer also receives
additional compensation through standard benefit plans available to all
employees, including but not limited to matching contributions pursuant to a
401(k) plan, paid vacation, and group health, life, and disability insurance.
The Compensation Committee believes each of these benefits is an integral part
of the overall compensation program that helps to ensure that our executive
officers receive competitive compensation.

Stock Options. Executive compensation includes the grant of stock options in
order to more closely align the interests of the executive with the long-term
interests of the shareholders.

Performance Graph

The following graph compares cumulative total shareholder return of UCI's common
stock over a five-year period with The NASDAQ Stock Market (US) Index and with a
Peer Group of companies for the same period. Total shareholder return represents
stock price changes and assumes the reinvestment of dividends. The graph assumes
the investment of $100 on September 30, 2000.






                          Insert Performance Graph Here








<TABLE>
<S>                                <C>            <C>           <C>             <C>           <C>          <C>
                                                                   Fiscal Year Ended
                                   -----------------------------------------------------------------------------------
                                    09/30/00      09/30/01       09/30/02       09/30/03      09/30/04      09/30/05
                                   -----------    ----------    -----------     ----------    ----------    ----------
UCI Medical Affiliates, Inc.           100.00         77.50          65.00         297.50        297.50        717.50
Peer Group                             100.00        263.40         192.17         288.74        359.84        521.08
NASDAQ Market Index                    100.00         40.97          32.96          50.52         53.56         60.93
</TABLE>

The members of the Peer Group are Continucare Corporation, IntegraMed America,
Inc., Pediatrix Medical Group, Inc., and Metropolitan Health Networks. The
returns of each company in the Peer Group have been weighted according to their
respective stock market capitalization for purposes of arriving at a Peer Group
average. The prices of UCI's common stock used in computing the returns
reflected above are the average of the high and low bid prices reported for
UCI's common stock during the fiscal year ended on such dates.

     Item 12. Security Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters

The following table sets forth certain information known to us regarding the
beneficial ownership of our common stock as of September 30, 2005. Information
is presented for (i) stockholders owning more than five percent of the
outstanding common stock as indicated in their respective Schedule 13D filings
as filed with the Securities and Exchange Commission as of September, 2005, (ii)
each of our directors, each nominee for director, and each of our executive
officers individually, and (iii) all of our directors and executive officers, as
a group. The percentages are calculated based on 9,740,472 shares of common
stock outstanding on September 30, 2005.


<PAGE>


<TABLE>
<S>                                                                          <C>                   <C>
                                                                                 Shares
                                                                              Beneficially
                                  Name                                         Owned (1)            Percentage
------------------------------------------------------------------------- -----------------         -------------
Blue Cross Blue Shield of South Carolina (2)...................................6,726,019                  69.05
Harold H. Adams, Jr................................................................2,500                     *
Joseph A. Boyle, CPA...................................................................0                      0
Jean E. Duke, CPA..................................................................2,000                      *
Ashby M. Jordan, M. D................................................................. 0                      0
John M. Little, Jr., M.D...............................................................0                      0
Charles M. Potok.......................................................................0                      0
Timothy L. Vaughn, CPA.................................................................0                      0
D. Michael Stout, M.D. (3).......................................................393,985                    4.04
Jerry F. Wells, Jr. (4)..........................................................109,825                    1.13
All current directors and executive officers
    As a group (9 persons).......................................................508,310                    5.20
</TABLE>

* Amount represents less than 1.0 percent.

(1)      Beneficial ownership reflected in the table is determined in accordance
         with the rules and regulations of the SEC and generally includes voting
         or investment power with respect to securities. Shares of common stock
         issuable upon the exercise of options currently exercisable or
         convertible, or exercisable or convertible within 60 days, are deemed
         outstanding for computing the percentage ownership of the person
         holding such options, but are not deemed outstanding for computing the
         percentage ownership of any other person. Except as otherwise
         specified, each of the stockholders named in the table has indicated to
         us that such stockholder has sole voting and investment power with
         respect to all shares of common stock beneficially owned by that
         stockholder.

(2)      The business address of the named beneficial owner is I-20 at Alpine
         Road, Columbia, SC 29219. The shares reflected in the table are held of
         record by BlueChoice HealthPlan ("BCHP") [formerly known as Companion
         HealthCare Corporation `CHC'] 6,107,838 shares and Companion Property &
         Casualty Corporation ("CP&C") 618,181 shares, wholly owned subsidiaries
         of Blue Cross Blue Shield of South Carolina.

     (3) Includes 89,825 shares issuable pursuant to currently exercisable stock
options and 10,000 shares held by Dr. Stout's spouse, Paulette J. Stout.

(4)      All shares are issuable pursuant to currently exercisable stock
         options.


Equity Compensation Plan Information

The following table provides information about our common stock authorized for
issuance under all of our existing equity compensation plans as of September 30,
2005.
<TABLE>
<S>                                   <C>                       <C>                         <C>
                                                                                               Number of securities
                                                                                             remaining available for
                                       Number of securities                                   future issuance under
                                        to be issued upon           Weighted-average           equity compensation
                                           exercise of             exercise price of             plans [excluding
                                       outstanding options,       outstanding options,       securities reflected in
          Plan category                warrants and rights        warrants and rights              column (a)]
----------------------------------    -----------------------    -----------------------     -------------------------
----------------------------------    -----------------------    -----------------------     -------------------------
                                               (a) (b) (c)
Equity     compensation     plans
approved by security holders                 240,650                      2.27                       438,250

Equity   compensation  plans  not
approved by security holders
                                                --                         --                           --
                                      -----------------------    -----------------------     -------------------------
                                      -----------------------    -----------------------     -------------------------

     Total                                   240,650                      2.27                       438,250
                                      =======================    =======================     =========================
</TABLE>



<PAGE>


Item 13.   Certain Relationships and Related Transactions

Administrative Services Agreements

As used in this Form 10-K, the term UCI-SC refers to UCI Medical Affiliates of
South Carolina, Inc., our wholly-owned subsidiary; the term DC-SC refers to
Doctors Care P.A., a professional corporation affiliated with us; the term DC-TN
refers to Doctor's Care of Tennessee, P.C., a professional corporation
affiliated with us; the term PPT refers to Progressive Physical Therapy, P.A., a
professional corporation affiliated with us; the term COSM refers to Carolina
Orthopedic & Sports Medicine, P.A., a professional corporation affiliated with
us; and the term P.A. refers collectively to DC-SC, DC-TN, PPT and COSM.

UCI-SC has entered into Administrative Services Agreements with each of the P.A.
Under these Administrative Services Agreements, which have an initial term of
forty years, UCI-SC performs all non-medical management for the P.A. and has
exclusive authority over all aspects of the business of the P.A. (other than
those directly related to the provision of patient medical services or as
otherwise prohibited by state law). The non-medical management provided by
UCI-SC includes, among other functions, treasury and capital planning, financial
reporting and accounting, pricing decisions, patient acceptance policies,
setting office hours, contracting with third party payors, and all
administrative services. UCI-SC provides all of the resources (systems,
procedures and staffing) to bill third party payors or patients, and provides
all of the resources (systems, procedures and staffing) for cash collection and
management of accounts receivables, including custody of the lockbox where cash
receipts are deposited. From the cash receipts, UCI-SC pays all physician and
physical therapist salaries, and all other operating costs of the centers and of
UCI-SC. UCI-SC sets compensation guidelines for the licensed medical
professionals at the P.A. and establishes guidelines for establishing,
selecting, hiring, and firing of the licensed medical professionals. UCI-SC also
negotiates and executes substantially all of the provider contracts with third
party payors, with the P.A. executing certain of the contracts at the request of
a minority of payors. UCI-SC does not loan or otherwise advance funds to any
P.A. for any purpose.

During our fiscal years ended September 30, 2005 and 2004, the P.A. received an
aggregate of approximately $56,642,000 and $47,474,000, respectively, in fees
prior to deduction by the P.A. of their payroll and other related deductible
costs covered under the Administrative Services Agreements. For accounting
purposes, we combine the operations of the P.A. with our operations, as
reflected in our consolidated financial statements.

D. Michael Stout, M.D. is the sole shareholder of DC-SC, DC-TN and COSM, and
since November 1, 2002, has served as the President and Chief Executive Officer
of UCI, UCI-SC, DC-SC and DC-TN. Since its incorporation on April 1, 2005, Dr.
Stout has served as the President of COSM. Prior to November 1, 2002, Dr. Stout
was the Executive Vice President of Medical Affairs for UCI and UCI-SC, and was
the President of DC-SC and DC-TN. Barry E. Fitch, P.T. is the sole shareholder
of PPT and has served as its President since the incorporation of PPT on April
5, 2005.

Medical Center Leases

A partnership in which M. F. McFarland III, MD., our former Chief Executive
Officer and Chairman of the Board, is a general partner leases to UCI-SC the
Doctors Care Northeast facility. We renewed the lease in October 1997 for a
fifteen-year term. We believe the terms of this lease to be no more or less
favorable to UCI-SC than those that would have been obtainable through
arm's-length negotiations with unrelated third parties for similar arrangements.
Total lease payments made by UCI-SC under this lease during the fiscal years
ended September 30, 2005 and 2004 were $96,000 each year, plus utilities and
real estate taxes.

Other Transactions with Related Parties

As of September 30, 2005, BlueChoice HealthPlan ("BCHP") [formerly known as
Companion Healthcare Corporation `CHC'], a wholly owned subsidiary of Blue Cross
Blue Shield of South Carolina ("BCBS"), owns 6,107,838 shares of our common
stock and Companion Property and Casualty Insurance Company ("CP&C"), another
wholly owned subsidiary of BCBS, owns 618,181 shares of our common stock, which
combine to approximately 69.05 percent of our outstanding common stock. The
following is a historical summary of purchases of our common stock by BCBS
subsidiaries from us.


<PAGE>





<TABLE>
<S>         <C>             <C>                                <C>    <C>           <C>            <C>

                              Blue Cross Blue Shield of South                          Price            Total
              Date                        Carolina                     Number           per           Purchase
            Purchased                    Subsidiary                   of Shares        Share            Price
       -------------------  -------------------------------------   --------------  ------------  ------------------
                            BlueChoice HealthPlan
            12/10/93                                             *      333,333        $1.50          $ 500,000
                            BlueChoice HealthPlan
            06/08/94                                             *      333,333        3.00            1,000,000
                            BlueChoice HealthPlan
            01/16/95                                             *      470,588        2.13            1,000,000
                            BlueChoice HealthPlan
            05/24/95                                             *      117,647        2.13              250,000
                            BlueChoice HealthPlan
            11/03/95                                             *      218,180        2.75              599,995
                            BlueChoice HealthPlan
            12/15/95                                             *      218,180        2.75              599,995
                            BlueChoice HealthPlan
            03/01/96                                             *      315,181        2.75              866,748

            06/04/96        Companion Property and Casualty             218,181        2.75              599,998

            06/23/97        Companion Property and Casualty             400,000        1.50              600,000
</TABLE>

         *BlueChoice HealthPlan ("BCHP") [formerly known as Companion HealthCare
Corporation `CHC'].

Our common stock acquired by BCHP and CP&C was purchased pursuant to exemptions
from the registration requirements of federal securities laws available under
Section 4(2) of the 1933 Act. Consequently, the ability of the holders to resell
such shares in the public market is subject to certain limitations and
conditions. BCHP and CP&C purchased these shares at share prices below market
value at the respective dates of purchase in part as a consequence of the lower
issuance costs incurred by us in the sale of these unregistered securities and
in part as consequence of the restricted nature of the shares. BCHP and CP&C
have the right to require registration of the stock under certain circumstances
as described in the respective stock purchase agreements.

From time to time, BCHP has purchased additional shares of our common stock
directly from other stockholders of the company. We were not a party to those
transactions.

BCHP and CP&C have the option to purchase as many shares from us as may be
necessary for BCBS and its subsidiaries in the aggregate to obtain and maintain
ownership of 48 percent of the outstanding common stock. To the extent either of
these BCBS subsidiaries exercises its right in conjunction with a sale of voting
stock by us, the price to be paid by such entity is the average price to be paid
by the other purchasers in that sale. Otherwise, the price is the average
closing bid price of our voting stock on the ten trading days immediately
preceding the election by a BCBS subsidiary to exercise its purchase rights.
Consequently, to the extent either of the BCBS subsidiaries elects to exercise
any or a portion of its rights under these anti-dilution agreements, the sale of
shares of common stock to a BCBS subsidiary will have the effect of reducing the
percentage voting interest in us represented by a share of the common stock.

During the fiscal year ended September 30, 1998, UCI-SC entered into a capital
lease purchase agreement with BCBS for a new billing and accounts receivable
system, which includes computer equipment, for an aggregate purchase price of
$1,253,000. UCI-SC has the option to purchase the equipment at the end of the
lease term for $1. The lease obligation recorded at September 30, 2005 is
$95,200, which includes lease addenda. We believe the terms of the lease
purchase agreement to be no more or less favorable to UCI-SC than the terms that
would have been obtainable through arm's-length negotiations with unrelated
third parties for a similar billing and accounts receivable system, which
includes computer equipment.

During the fiscal year ended September 30, 1994, UCI-SC entered into an
agreement with CP&C pursuant to which UCI-SC, through DC-SC, acts as the primary
care provider for injured workers of firms carrying worker's compensation
insurance through CP&C. Additionally, during the fiscal year ended September 30,
1995, UCI-SC executed a $400,000 note payable to CP&C payable in monthly
installments of $4,546 (including 11 percent interest) from April 1, 1995 to
March 1, 2010. We believe the terms of the agreement with CP&C to be no more or
less favorable to UCI-SC than those that would have been obtainable through
arm's-length negotiations with unrelated third parties for similar arrangements.



<PAGE>


UCI-SC, through DC-SC, provides services to members of a health maintenance
organization operated by BCHP who have selected DC-SC as their primary care
provider. We believe the terms of the agreement with BCHP to be no more or less
favorable to UCI-SC than those that would have been obtainable through
arm's-length negotiations with unrelated third parties for similar arrangements.

Item 14.  Principal Accountant Fees and Services

Audit Committee Report

The Audit Committee's charter, as revised as of June 9, 2005, specifies that the
purpose of the Committee is to oversee and monitor:

         (1)      the integrity of the company's accounting and financial
                  reporting process, including the financial reports and other
                  financial information provided by the company to the public,

         (2)      the independence and qualifications of the company's external
                  auditor,

         (3)      the performance of the company's external auditor,

         (4)      the company's system of internal accounting and financial
                  controls,

         (5)      the company's system of public and private disclosure
                  controls, and the company's compliance with laws, regulations,
                  and the company's Code of Ethics and any other code of ethics
                  applicable to the company.

The full text of the Charter was filed as Appendix A to our Proxy Statement
which was filed with the Securities and Exchange Commission on June 13, 2005. In
carrying out its responsibilities, the Audit Committee, among other things

         (1)      monitors preparation of quarterly and annual financial reports
                  by our management;

         (2)      supervises the relationship between us and our independent
                  auditors, including: having direct responsibility for our
                  auditor's appointment, compensation, and retention; reviewing
                  the scope of our auditor's audit services; approving
                  significant non-audit services; and confirming the
                  independence of our auditors; and

         (3)      oversees management's implementation and maintenance of
                  effective systems of internal and disclosure controls.

The Committee schedules its meetings with a view to ensuring that it devotes
appropriate attention to all of its tasks. The Committee's meetings include,
whenever appropriate, executive sessions with our independent auditors and with
our internal auditors.

As part of its oversight of our financial statements, the Committee reviewed and
discussed with both management and our independent auditors the audited
consolidated financial statements for the year ended September 30, 2005.
Management advised the Committee that these financial statements had been
prepared in accordance with generally accepted accounting principles. The
discussions with Scott McElveen, L.L.P. also included the matters required by
Statement on Auditing Standards No. 61 (Communication with Audit Committees) as
amended by Statement on Auditing Standards No. 90, including the quality of our
accounting principles, the reasonableness of significant judgments, and the
clarity of the disclosures in our financial statements. The Committee also
discussed with Scott McElveen, L.L.P. matters relating to Scott McElveen
L.L.P.'s independence, including a review of audit and non-audit fees and the
written disclosures and letter from Scott McElveen, L.L.P. to the Committee as
required by Independence Standards Board Standard No. 1 (Independence
Discussions with Audit Committees).



<PAGE>


Based on the above-described discussions and reviews, the Audit Committee
recommended to the Board that the Board approve the inclusion of our audited
consolidated financial statements in our Annual Report on Form 10-K for the year
ended September 30, 2005 for filing with the Securities and Exchange Commission.


         Submitted by the Audit Committee of the Board of Directors.

         Joseph A. Boyle, CPA, Chairman
         Harold H. Adams, Jr.
         Jean E. Duke, CPA

Audit Fees

The following table presents for the fiscal years ending September 30, 2005 and
2004 under the heading: (1) "Audit Fees," the aggregate fees billed for
professional services rendered by Scott McElveen, L.L.P. for the audit of our
annual financial statements and review of financial statements included in our
Forms 10-Q and for services that are normally provided by Scott McElveen, L.L.P.
in connection with our statutory and regulatory filings or engagements; (2)
"Audit-Related Fees," the aggregate fees billed for assurance and related
services by Scott McElveen, L.L.P. that are reasonably related to the
performance of the audit or review of our financial statements; and, (3) "Tax
Fees," the aggregate fees billed for professional services rendered by Scott
McElveen, L.L.P. for tax compliance, tax advice, and tax planning.
<TABLE>
<S>                                        <C>                <C>
                                              FY05                FY04
                                           -----------         -----------
                                           -----------         -----------
Audit Fees(1)                              $81,000             $66,125
Audit Related Fees(2)                          8,000           $  7,350
Tax Fees(3)                                  14,000            $16,500
</TABLE>

(1) Includes primarily fees relating to the audit of the Company's annual
   financial statements and for reviews of the financial statements included in
   the Company's reports on Form 10-Q.

     (2) Includes fees for services related to the audit of the Company's 401(k)
Plan and Form 5500 preparation.

3     Includes fees related to tax compliance, and tax advice.

The Audit Committee pre-approved all audit related services, tax services, and
other services and concluded that provision of these services was compatible
with maintaining Scott McElveen, L.L.P.'s independence in conducting its audit
services.


<PAGE>


                                     PART IV


Item 15.   Exhibits and Financial Statement Schedules

(a)(1)    Consolidated Financial Statements
          The consolidated financial statements listed on the Index to Financial
          Statements on page 36 are filed as part of this report on Form 10-K.

(a)(2) Financial Statement Schedules Required by Item 8

(a)(3)     Exhibits
           A listing of the exhibits to the Form 10-K is set forth on the
           Exhibit Index that immediately precedes such exhibits in this Form
           10-K.






<PAGE>

<TABLE>
<S>                                                                                                      <C>
                   INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

                                                                                                         Page(s)

Report of Independent Registered Accounting Firm.............................................................37

Consolidated Balance Sheets at September 30, 2005 and 2004...................................................38

Consolidated Statements of Operations for each of the three years
         ended September 30, 2005............................................................................39

Consolidated Statements of Changes in Stockholders' Equity
         for each of the three years ended September 30, 2005................................................40

Consolidated Statements of Cash Flows for each of the three years
         ended September 30, 2005............................................................................41

Notes to Consolidated Financial Statements................................................................42-55
</TABLE>


Schedule II, Valuation and Qualifying Accounts, is omitted because the
information is included in the financial statements and notes.






















<PAGE>









             Report of Independent Registered Public Accounting Firm






To the Board of Directors and
Stockholders of UCI Medical Affiliates, Inc.
Columbia, South Carolina

We have audited the accompanying consolidated balance sheets of UCI Medical
Affiliates, Inc. and its subsidiaries (the "Company") as of September 30, 2005
and 2004, and the related consolidated statements of operations, changes in
stockholders' equity, and cash flows for each of the three years in the period
ended September 30, 2005. These financial statements are the responsibility of
the Company's management. Our responsibility is to express an opinion on these
financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes consideration of
internal control over financial reporting as a basis for designing audit
procedures that are appropriate in the circumstances, but not for the purpose of
expressing an opinion on the effectiveness of the Company's internal control
over financial reporting. Accordingly, we express no such opinion. An audit also
includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements assessing the accounting principles used
and significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the financial position of the Company as of
September 30, 2005 and 2004, and the consolidated results of its operations and
its cash flows for each of the three years in the period ended September 30,
2005, in conformity with accounting principles generally accepted in the United
States of America.


/S/ SCOTT MCELVEEN, L.L.P.


Columbia, South Carolina
November 23, 2005
..

              SIGNED ORIGINAL ON SCOTT MCELVEEN, L.L.P. LETTERHEAD
                      IS ON FILE IN THE CORPORATE OFFICE OF
                          UCI MEDICAL AFFILIATES, INC.



<PAGE>



<TABLE>
<S> <C>                                                                 <C>                 <C>
                                UCI Medical Affiliates, Inc.
                                 Consolidated Balance Sheets
                                                                                    September 30,
                                                                         -------------------------------------
                                                                               2005                2004
                                                                         -----------------    ----------------
Assets
Current assets
   Cash and cash equivalents                                             $                    $
                                                                         961,610              533,533
   Accounts receivable, less allowance for doubtful accounts
     of $2,949,127 and $2,368,464                                              8,778,025            7,382,619
   Inventory                                                                     623,941              618,446
   Deferred taxes                                                              1,319,457              500,000
   Prepaid expenses and other current assets                                     192,279              266,788
                                                                         -----------------    ----------------
Total current assets                                                          11,875,312            9,301,386

Property and equipment, less accumulated depreciation of
   $11,327,037 and $10,307,556                                                 6,013,236            4,845,296
Deferred taxes                                                                 2,104,606                   --
Excess of cost over fair value of assets acquired, less
    accumulated amortization of $2,451,814                                     3,391,942            3,391,942
Other assets                                                                      14,278               10,322
                                                                         -----------------    ----------------
Total Assets                                                             $                    $
                                                                         23,399,374           17,548,946
                                                                         =================    ================

Liabilities and Stockholders' Equity
Current liabilities
   Current portion of long-term debt                                     $                    $
                                                                               1,259,315              972,108
   Accounts payable                                                              882,988            1,669,565
   Accrued salaries and payroll taxes                                          1,979,048            1,926,095
   Current portion of pre-petition payroll taxes                                      --              595,744
   Accrued uncompensated absences                                                320,434              301,601
   Other accrued liabilities                                                     743,862              608,308
                                                                         -----------------    ----------------
                                                                         -----------------    ----------------
Total current liabilities                                                      5,185,647            6,073,421
                                                                         -----------------    ----------------
                                                                         -----------------    ----------------

Long-term liabilities
   Accounts payable                                                            1,115,711            1,193,935
   Deferred tax liability                                                        278,211                   --
   Long-term portion of pre-petition payroll taxes                                    --            1,970,102
   Long-term debt, net of current portion                                      3,498,790            2,531,789
                                                                         -----------------    ----------------
Total long-term liabilities                                                    4,892,712            5,695,826
                                                                         -----------------    ----------------
                                                                         -----------------    ----------------
Total Liabilities                                                             10,078,359           11,769,247
                                                                         -----------------    ----------------

Commitments and contingencies (Note 16)

Stockholders' Equity
   Preferred stock, par value $.01 per share:
    Authorized shares - 10,000,000; none issued                                       --                   --
   Common stock, par value $.05 per share:
    Authorized shares - 50,000,000
    Issued and outstanding- 9,740,472 shares                                     487,024              487,024
   Paid-in capital                                                            21,719,130           21,719,130
   Accumulated deficit                                                        (8,885,139)         (16,426,455)
                                                                         -----------------    ----------------
Total Stockholders' Equity                                                    13,321,015            5,779,699
                                                                         -----------------    ----------------

Total Liabilities and Stockholders' Equity                               $                    $
                                                                         23,399,374           17,548,946
                                                                         =================    ================
</TABLE>

                        The accompanying notes are an integral part of these
consolidated financial statements.


<PAGE>



<TABLE>
<S>                                                           <C>                      <C>                   <C>
                                UCI Medfical Affiliates, Inc.
                             Consolidated Statement of Operations
                                                                          For the Three Years Ended September 30,
                                                              -----------------------------------------------------------------
                                                                     2005                    2004                  2003
                                                               ------------------      -----------------     ------------------

Revenues                                                       $   56,641,717          $   47,473,880        $   43,518,068
Operating costs                                                     42,309,660              36,732,966            33,264,015
                                                               ------------------      -----------------     ------------------
Operating margin                                                    14,332,057              10,740,914            10,254,053

General and administrative expenses                                  7,791,365               6,250,282             5,990,293
Depreciation and amortization                                        1,019,481               1,013,114             1,144,631
                                                               ------------------      -----------------     ------------------
Income from operations                                               5,521,211               3,477,518             3,119,129
                                                               ------------------      -----------------     ------------------
                                                               ------------------      -----------------     ------------------

Other expense
  Interest expense, net of interest income                             (548,855)              (692,581)             (743,763)
                                                               ------------------      -----------------     ------------------

Income before income taxes                                            4,972,356               2,784,937             2,375,366

Income tax benefit                                                    2,568,960                                           --
                                                                                       429,000
                                                               ------------------      -----------------     ------------------
                                                               ------------------      -----------------     ------------------

Net income                                                     $     7,541,316         $     3,213,937       $     2,375,366
                                                               ==================      =================     ==================
                                                               ==================      =================     ==================

Basic earnings per share                                             $.77                    $.33                  $.25
                                                               ==================      =================     ==================
                                                               ==================      =================     ==================

Basic weighted average common shares outstanding                     9,740,472               9,717,849             9,650,472
                                                               ==================      =================     ==================

Diluted earnings per share                                           $.76                    $.33                  $.25
                                                               ==================      =================     ==================
                                                               ==================      =================     ==================

Diluted weighted average common shares outstanding                    9,879,345               9,717,849            9,650,472
                                                               ==================      =================     ==================
</TABLE>

                        The accompanying notes are an integral part of these
consolidated financial statements.


<PAGE>


<TABLE>
<S>                                 <C>               <C>               <C>                  <C>                     <C>
                                  UCI Medical Affiliates, Inc.
                          Consolidated Statements of Changes in Stockholders' Equity
                                  For the Three Years Ended September 30, 2005
                                            Common Stock
                                   -------------------------------
                                                                                                  Accumulated
                                      Shares          Par Value         Paid-In Capital            Deficit                Total
                                   --------------    -------------     ------------------     -------------------     ------------
                                   --------------    -------------     ------------------     -------------------     ------------
Balance, September 30, 2002          9,650,515        $482,524           $21,723,630            $(22,015,758)          $   190,396
   Net income                               --                --                --                 2,375,366             2,375,366
   Other                                   (43)               --                --                     --                      --
                                   --------------    -------------     ------------------     -------------------     ------------
                                   --------------    -------------     ------------------     -------------------     ------------
Balance, September 30, 2003          9,650,472        $482,524           $21,723,630            $(19,640,392)           $2,565,762
   Net income                               --                --                --                 3,213,937             3,213,937
   Other                                90,000           4,500                (4,500)                  --                      --
                                   --------------    -------------     ------------------     -------------------     ------------
                                   --------------    -------------     ------------------     -------------------     ------------
Balance, September 30, 2004          9,740,472        $487,024           $21,719,130            $(16,426,455)           $5,779,699
                                   --------------    -------------     ------------------     -------------------     ------------
                                   --------------    -------------     ------------------     -------------------     -------------
   Net income                               --                --                --                 7,541,316             7,541,316
   Other                                    --                --                --                     --                      --
                                   --------------    -------------     ------------------     -------------------     -------------
                                   --------------    -------------     ------------------     -------------------     -------------
Balance, September 30, 2005          9,740,472        $487,024           $21,719,130             $(8,885,139)          $13,321,015
                                   ==============    =============     ==================     ===================     =============
</TABLE>

                        The accompanying notes are an integral part of these
consolidated financial statements.

<PAGE>



<TABLE>
<S>   <C>                                                              <C>                 <C>                <C>
                                    UCI Medical Affiliates, Inc.
                                  Consolidated Statements of Cash Flows
                                                                              For the Three Years Ended September 30,
                                                                        -----------------------------------------------------
                                                                            2005               2004                2003
                                                                        --------------    ----------------    ---------------
Operating activities:
Net income                                                                $ 7,541,316         $ 3,213,937        $ 2,375,366
Adjustments to reconcile net income to net
   cash provided by operating activities:
      Provision for losses on accounts receivable                           3,108,369           2,358,571          1,888,594
      Depreciation and amortization                                         1,019,481           1,013,114          1,144,631
      Deferred taxes                                                      (2,645,852)          (500,000))              --
Changes in operating assets and liabilities:
      Increase in accounts receivable                                     (4,503,775)         (2,866,767)        (2,413,388)
      (Increase) decrease in inventory                                        (5,495)              27,874          (252,525)
      (Increase) decrease in prepaid expenses and other current assets                           (39,122)             69,512
                                                                        74,509
      Increase (decrease) in accounts payable and accrued expenses        (1,174,981)             541,280            780,264
                                                                        --------------    ----------------    --------------
Cash provided by operating activities                                       3,413,572           3,748,887          3,592,454
                                                                        --------------    ----------------    ---------------

Investing activities:
Purchases of property and equipment                                       (2,187,421)         (1,830,643)        (1,407,853)
(Increase) decrease in other assets                                           (3,956)             (2,500)             42,661
                                                                        --------------    ----------------    ---------------

Cash used in investing activities                                         (2,191,377)         (1,833,143)        (1,365,192)
                                                                        --------------    ----------------    ---------------

Financing activities:
Borrowings on term note agreement                                           4,300,000           2,750,000              --
Payments on long-term debt                                                (3,045,792)         (2,572,789)
                                                                                                                   (751,792)
Payments on other obligations                                             (2,048,326)         (2,242,557)        (1,061,633)
                                                                        --------------    ----------------    ---------------

Cash used in financing activities                                           (794,118)         (2,065,346)        (1,813,425)
                                                                        --------------    ----------------    ---------------

Increase (decrease) in cash and cash equivalents                              428,077           (149,602)            413,837
Cash and cash equivalents at beginning of year                                533,533             683,135            269,298
                                                                        --------------    ----------------
                                                                        --------------    ----------------    ---------------

Cash and cash equivalents at end of year                                    $ 961,610          $  533,533          $ 683,135
                                                                        ==============    ================    ===============
</TABLE>

                        The accompanying notes are an integral part of these
consolidated financial statements.


<PAGE>



                          UCI MEDICAL AFFILIATES, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


NOTE 1.  BUSINESS AND BASIS OF PRESENTATION

 The consolidated financial statements include the accounts of UCI Medical
Affiliates, Inc. ("UCI"), UCI Medical Affiliates of South Carolina, Inc.
("UCI-SC"), Doctors Care, P.A., Progressive Physical Therapy, P.A. ("PPT"),
Carolina Orthopedic & Sports Medicine, P.A. ("COSM"), and Doctors Care of
Tennessee, P.C. (the four together as the "P.A." and together with UCI and
UCI-SC, the "Company"). Because of the corporate practice of medicine laws in
the states in which the Company operates, the Company does not own medical
practices but instead enters into exclusive long-term management services
agreements with the P.A. that operates the medical practices. Consolidation of
the financial statements is required under Financial Accounting Standards Board
(FASB) Interpretation No. 46, as revised, ("FIN 46") "Consolidation of Variable
Interest Entities." Prior to the Company's adoption of FIN 46 on October 1,
2003, the Company consolidated the P.A. as a result of Emerging Issues Task
Force ("EITF") No. 97-2, "Application of FASB Statement No. 94 and APB Opinion
No. 16 to Physician Practice Management Entities and Certain Other Entities with
Contractual Management Arrangements." UCI-SC, in its sole discretion, can effect
a change in the nominee shareholder of each of the P.A. at any time for a
payment of $100 from the new nominee shareholder to the old nominee shareholder,
with no limits placed on the identity of any new nominee shareholder and no
adverse impact resulting to any of UCI-SC or the P.A. from such change.

In addition to the nominee shareholder arrangement described above, UCI-SC has
entered into an Administrative Service Agreement with each of the P.A. As a
consequence of the nominee shareholder arrangement and the Administrative
Service Agreement, the Company has a long-term financial interest in the
affiliated practices of each P.A. and the Company has exclusive authority over
decision-making relating to all major on-going operations. The Company
establishes annual operating and capital budgets for the P.A. and compensation
guidelines for the licensed medical professionals. The Administrative Service
Agreements have an initial term of forty years. According to FASB Statement No.
94 (Consolidation of All Majority-Owned Subsidiaries), and FIN No. 46, the
Company must consolidate the results of the affiliated practices with those of
the Company. All significant intercompany accounts and transactions are
eliminated in consolidation, including management fees.

On May 27, 2005, UCI-SC entered into an Administrative Service Agreement with
Progressive Physical Therapy, P.A., a South Carolina professional corporation
("PPT"). A copy of the Administrative Service Agreement was filed as Exhibit
10.32 to the Form 8-K filed with the Securities and Exchange Commission on May
31, 2005. Pursuant to the agreement, PPT will serve as the operating entity for
the physical therapy services managed and administered by UCI-SC.

On May 27, 2005, UCI-SC entered into an Administrative Service Agreement with
Carolina Orthopedic & Sports Medicine, P.A., a South Carolina professional
corporation ("COSM"). A copy of the Administrative Service Agreement was filed
as Exhibit 10.34 to the Form 8-K filed with the Securities and Exchange
Commission on May 31, 2005. Pursuant to the agreement, COSM will serve as the
operating entity for the orthopedic and sports medicine services managed and
administered by UCI-SC.

The method of computing the management fees is based on billings of the
affiliated practices less the amounts necessary to pay professional compensation
and other professional expenses. In all cases, these fees are meant to
compensate the Company for expenses incurred in providing covered services plus
a profit. These interests are unilaterally salable and transferable by the
Company and fluctuate based upon the actual performance of the operations of the
professional corporation.

The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make certain estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosures of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenue and expenses during the reporting
period. The most significant estimates are related to the allowance for doubtful
accounts, goodwill and intangible assets, income taxes, contingencies, and
health insurance accruals.



<PAGE>


The Company bases its estimates on historical experience and on various other
assumptions that are believed to be reasonable under the circumstances, the
results of which form the basis for making judgments about the carrying value of
assets and liabilities that are not readily apparent from other sources. Actual
results may differ from these estimates in the near term.

Revenue is recognized at estimated net amounts to be received from patients,
employers, third party payors, and others at the time the related services are
rendered. The Company records contractual adjustments at the time bills are
generated for services rendered as some third parties are billed at discounted
and negotiated amounts. Whenever the Company bills at the discounted amounts,
estimates of third party settlements are not necessary.

Accounts Receivable

Accounts receivable are primarily amounts due under fee-for-service contracts
from third-party payors, such as insurance companies, self-insured employers and
patients and government-sponsored health care programs. Concentration of credit
risk related to accounts receivable is limited by number, diversity and
geographic dispersion of the business units managed by the Company, as well as
by the large number of patients and payors, including the various governmental
agencies in the state. The accounts receivable balances serve as collateral for
certain of the Company's financing arrangements.

Allowance for Doubtful Accounts

The Company maintains an allowance for doubtful accounts for estimated losses,
which may result from the inability of customers to make required payments. The
allowance is based on the likelihood of recoverability of accounts receivable
considering such factors as past experience and current collection trends.
Factors taken into consideration in estimating the allowance include: amounts
past due, in dispute, or a client that may be having financial difficulties. If
economic, industry, or specific customer business trends worsen beyond earlier
estimates, the allowance for doubtful accounts is increased by recording
additional bad debt expense.

Certain reclassifications have been made to fiscal years 2003 and 2004 to
conform to the fiscal year 2005 presentation.

Stock Based Compensation

The Company has adopted FASB Statement No. 148 and the disclosure-only
provisions of Statement No. 123, "Accounting for Stock-Based Compensation." The
Company records compensation expense for stock options only if the market price
of the Company's stock, on the date of grant, exceeds the amount an individual
must pay to acquire the stock, if dilutive. See Note 12 for further discussion.

Income Taxes

Deferred tax assets and liabilities are recorded based on the difference between
the financial statement and tax bases of assets and liabilities as measured by
the enacted tax rates which are anticipated to be in effect when these
differences reverse. The deferred tax provision is the result of the net change
in the deferred tax assets to amounts expected to be realized. Valuation
allowances are provided against deferred tax assets when the Company determines
it is more likely than not that the deferred tax asset will not be realized.

Cash and Cash Equivalents

The Company considers all short-term deposits with a maturity of three months or
less at acquisition date to be cash equivalents. At September 30, 2005, the
Company had cash deposits in excess of federally insured limits in the
approximate amount of $703,000.

Fair Value of Financial Instruments

The estimated fair value of financial instruments has been determined by the
Company using available market information and appropriate valuation
methodologies. However, considerable judgment is required in interpreting data
to develop the estimates of fair value. Accordingly, the estimates presented
herein are not necessarily indicative of the amounts that the Company could
realize in a current market exchange. The fair value estimates presented herein
are based on pertinent information available to management as of September 30,
2005 and 2004. Although management is not aware of any factors that would
significantly affect the estimated fair value amounts, such amounts have not
been comprehensively revalued for purposes of these financial statements since
that date and current estimates of fair value may differ significantly from the
amounts presented herein. The fair values of the Company's financial instruments
are estimated based on current market rates and instruments with the same risk
and maturities. The fair values of cash and cash equivalents, accounts
receivable, accounts payable, notes payable and payables to related parties
approximate the carrying values of these financial instruments.

Segment Information

Statement No. 131, "Disclosure about Segments of an Enterprise and Related
Information", requires companies to report financial and descriptive information
about their reportable operating segments, including segment profit or loss,
certain specific revenue and expense items, and segment assets, as well as
information about the revenues derived from the Company's products and services,
the countries in which the Company earns revenues and holds assets, and major
customers. This statement also requires companies that have a single reportable
segment to disclose information about products and services, information about
geographic areas, and information about major customers. This statement requires
the use of the management approach to determine the information to be reported.
The management approach is based on the way management organizes the enterprise
to assess performance and make operating decisions regarding the allocation of
resources. It is management's opinion that, at this time, the Company has
several operating segments, however, only one reportable segment. The following
discussion sets forth the required disclosures regarding single segment
information.

The Company provides nonmedical management and administrative services for a
network of 47 freestanding medical centers, 46 of which are located throughout
South Carolina and one is located in Knoxville, Tennessee (29 operating as
Doctors Care in South Carolina, one as Doctors Care in Knoxville, Tennessee, 15
as Progressive Physical Therapy Services in South Carolina, one as Luberoff
Pediatrics in South Carolina, and one as Carolina Orthopedic and Sports Medicine
in South Carolina).

NOTE 2.  NEW ACCOUNTING PRONOUNCEMENTS

In December 2004, FASB issued revised SFAS No. 123R, "Share-Based Payment". This
statement amends SFAS No. 123, "Accounting for Stock-Based Compensation". The
statement eliminates the alternative to use APB Opinion No. 25, "Accounting for
Stock Issued to Employees", that was provided in SFAS 123 as previously issued.
SFAS 123R requires entities to recognize the cost of employee services received
in exchange for awards of equity instruments based on the grant-date fair value
of those awards. The statement is effective as of the beginning of the first
interim or annual reporting period that begins after December 31, 2005 and
encourages early adoption.

In September 2004, the Financial Accounting Standards Board's Emerging Issue
Task Force ("EITF") reached a consensus on EITF Issue No. 04-08, "The Effect of
Contingently Convertible Instruments on Diluted Earnings per Share". The Task
Force reached a conclusion that Contingently Convertible Instruments ("Co-Cos")
should be included in diluted earnings per share computations, if dilutive,
regardless of whether the market price trigger or other contingent feature has
been met. Through September 30, 2005, EITF Issue No. 04-08 had no effect on the
Company.

In January 2003, the FASB issued FASB Interpretation No. 46 ("FIN 46"),
"Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51,"
which addresses consolidation by business enterprises of variable interest
entities ("VIEs") either: (1) that do not have sufficient equity investment at
risk to permit the entity to finance its activities without additional
subordinated financial support, or (2) in which the equity investors lack an
essential characteristic of a controlling financial interest. In December 2003,
the FASB issued modifications to FIN 46 ("Revised Interpretations") resulting in
multiple effective dates based on the nature as well as the creation date of the
VIE. VIEs created after January 31, 2003, but prior to January 1, 2004, may be
accounted for either based on the original interpretation or the Revised
Interpretations. However, the Revised Interpretations must be applied no later
than the first quarter of 2004. VIEs created after January 1, 2004 must be
accounted for under the Revised Interpretations. Non-Special Purpose Entities
created prior to February 1, 2003, should be accounted for under the Revised
Interpretation's provisions no later than the first quarter of fiscal 2004. As
of the beginning of 2004, the Company adopted FIN 46 and the Revised
Interpretations, neither of which had an impact on the Company's consolidated
financial statements because the VIE had previously been consolidated as a
result of other accounting pronouncements.


<PAGE>


The FASB issued SFAS No. 154, "Accounting Changes and Error Corrections - a
replacement of Accounting Principles Board (APB) Opinion No. 20 and FASB
Statement No. 3" in May 2005. This statement changes the requirements for the
accounting for and reporting of a change in accounting principle. SFAS No. 154
requires companies that make a voluntary change in accounting principle to apply
that change retrospectively to prior period's financial statements, unless this
would be impracticable. This statement will be effective for fiscal years
beginning after December 15, 2005. The Company will comply with the provisions
of this statement for any future accounting changes or error corrections.

NOTE 3.  MEDICAL SUPPLIES AND DRUG INVENTORY

The inventory consists of medical supplies and drugs and both are carried at the
lower of average cost or market. The volume of supplies carried at a center
varies very little from month to month and management, therefore, does only an
annual physical inventory count and does not maintain a perpetual inventory
system.

NOTE 4.  INTANGIBLES

     In June 2001,  the FASB  issued  Statement  No.  142,  "Goodwill  and Other
Intangible  Assets".  Statement No. 142 requires  that  goodwill and  intangible
assets with  indefinite  lives will no longer be amortized,  but are reviewed at
least annually for impairment. Pursuant to Statement No. 142, the Company tested
goodwill for impairment in the fourth quarter of 2005, and determined  there had
not been any impairment.

NOTE 5.  EARNINGS PER SHARE

Net income per share is computed in accordance with Statement of Financial
Accounting Standards ("SFAS") No. 128, "Earnings Per Share". Basic earnings per
share are calculated by dividing income available to common shareholders by the
weighted-average number of shares outstanding for each period. Diluted earnings
per common share are calculated by adjusting the weighted-average shares
outstanding assuming conversion of all potentially dilutive stock options. All
warrants and options to purchase shares of common stock were excluded from the
calculation at September 30, 2005, 2004, and 2003, respectively, because of
their antidilutive effect.

NOTE 6.  PROPERTY AND EQUIPMENT

Property and equipment is recorded at cost.

Depreciation is provided principally by the straight-line method over the
estimated useful lives of the assets, ranging from one to forty years.

Maintenance, repairs and minor renewals are charged to expense. Major renewals
or betterments, which prolong the life of the assets, are capitalized.

Upon disposal of depreciable property, the asset accounts are reduced by the
related cost and accumulated depreciation. The resulting gains and losses are
reflected in the consolidated statements of operations.



<PAGE>


Property and equipment consists of the following at September 30:

<TABLE>
<S>                             <C>            <C>            <C>                <C>           <C>

                                                    September 30, 2005                  September 30, 2004
                                             ----------------------------------    -----------------------------

                               Useful Life
                                  Range                        Accumulated                       Accumulated
                                (in years)        Cost        Depreciation           Cost        Depreciation
                               ------------- --------------- ----------------   --------------- ---------------
------------------------------ ------------- --------------- ----------------   --------------- ---------------
                                       5-40       $ 412,750       $  140,242         $ 412,750       $ 127,561
Building
                                        N/A          66,000              --             66,000              --
Land
                                       5-15       4,272,788        2,128,779         3,227,974       1,831,172
Leasehold Improvements
                                       1-10       2,499,647        1,652,536         2,150,779       1,480,513
Furniture & Fixtures
                                        1-5       1,402,274        1,304,436         1,402,274       1,304,436
EDP - Companion
                                       1-10       1,889,263        1,259,914         1,620,673       1,123,043
EDP - Other
                                       5-10       5,057,944        3,582,397         4,762,020       3,301,417
Medical Equipment
                                       1-10       1,672,027        1,202,848         1,442,802       1,090,025
Other Equipment
Autos                                  3-10          67,580           55,885            67,580          49,389

                                             --------------- ----------------   --------------- ---------------
                                                $17,340,273      $11,327,037       $15,152,852     $10,307,556
Totals
                                             =============== ================   =============== ===============
</TABLE>

At September 30, 2005 and 2004, capitalized leased equipment included above
amounted to approximately $119,000, net of accumulated amortization of $73,000
and $62,000, respectively.

Depreciation expense totaled $1,019,481, $1,013,114, and $1,144,631, for the
years ended September 30, 2005, 2004 and 2003, respectively.

NOTE 7.  ADVERTISING COSTS

Advertising and marketing costs are expensed as incurred. Advertising and
marketing costs were approximately $1,068,000, $681,000, and $470,000,
respectively, for each of the three fiscal years ended September 30, 2005, 2004
and 2003, respectively.

NOTE 8.  INCOME TAXES

The components of the benefit for income taxes for each of the three years ended
September 30 are as follows:
<TABLE>
<S><C>                                                     <C>                <C>                <C>

                                                               2005              2004               2003

                                                           -------------     --------------      -----------
                                                                             --------------      -----------

Current:
                                                              $ 100,000           $ 71,000       $
   Federal                                                                                               --
                                                                     --                 --               --
   State
                                                           -------------     --------------      -----------
                                                           -------------     --------------      -----------
                                                                100,000             71,000               --
                                                                             --------------      -----------
                                                           -------------     --------------      -----------

Deferred:
                                                            (2,668,960)          (500,000)
   Federal                                                                                               --
                                                                     --                 --               --
   State
                                                           -------------     --------------      -----------
                                                           -------------     --------------      -----------
                                                            (2,668,960)          (500,000)               --
                                                           -------------     --------------      -----------
                                                           -------------     --------------      -----------
                                                           $(2,568,960)         $(429,000)       $
Total income tax (benefit)                                                                               --
                                                           =============     ==============      ===========
</TABLE>

Deferred taxes result from temporary differences in the recognition of certain
items of income and expense, and the changes in the valuation allowance
attributable to deferred tax assets.



<PAGE>


At September 30, 2005, 2004, and 2003, the Company's deferred tax assets
(liabilities) and the related valuation allowances are as follows:
<TABLE>
<S>                                         <C>                 <C>               <C>

                                                2005               2004               2003

                                            -------------       ------------       ------------
                                                                ------------       ------------
                                            $                   $                  $
Accounts receivable                         1,128,041           905,937            712,183
                                                                                         23,377
Other                                       285,509             --
                                               1,948,362           4,160,049          5,156,716
Operating loss carry forwards
                                                (129,265)           (226,118)          (262,737)
Fixed assets
Goodwill                                        (278,211)
                                                                --                 --
Accruals                                         191,416             155,098            186,511
                                                                ------------       ------------
                                            -------------       ------------       ------------
                                                                $ 4,994,966        $5,816,050
                                            $3,145,852
                                            =============       ============       ============
                                                                ============       ============
                                            $                   $ 4,494,966        $5,816,050
Valuation allowance                         --
                                            =============       ============       ============
</TABLE>

The principal reasons for the differences between the consolidated income tax
(benefit) expense and the amount computed by applying the statutory federal
income tax rate of 35% to pre-tax income were as follows for the years ended
September 30:
<TABLE>
<S> <C>                                    <C>                 <C>                <C>

                                               2005                2004                2003

                                           -------------        ------------       -------------
                                             $1,760,583         $                  $
Tax at federal statutory rate                                   974,728            814,764

Effect on rate of:
                                                215,403              (62,808)           (60,919)
   Amortization of goodwill
                                                  8,294                7,350              9,755
   Non deductible expenses
                                                441,726              (27,186)            37,085
   State income taxes & other
                                             (4,994,966)          (1,321,084)          (800,685)
   Change in valuation allowance
                                           -------------        ------------       -------------
                                           $(2,568,960)         $ (429,000)        $         --

                                           =============        ============       =============
</TABLE>

At September 30, 2005, the Company has net tax operating loss (NOL)
carryforwards expiring in the following years ending September 30,
2020                 $3,681,057
2021                  1,112,283
2022                     18,660
2023                     63,181
2024                     71,858
2025                    146,717
                ----------------
                ----------------
                     $5,093,756

                ================

In determining that it was more likely than not that the recorded deferred tax
asset would not be realized, management of the Company considered the following:

o        Recent historical operating results.

o The budgets and forecasts that management and the Board of Directors had
adopted for the next fiscal year.

o The ability to utilize NOL's prior to their expiration.

o The potential limitation of NOL utilization in the event of a change in
ownership.

o The generation of future taxable income in excess of income reported on the
consolidated financial statements.



<PAGE>


During the year ended September 30, 2005, management determined that it was more
likely than not that the recorded deferred tax asset was realizable. Therefore,
a $4,500,000 adjustment was recorded to reduce the valuation allowance based
upon the Company's current financial position and results of operations, and the
forecast of the next twelve months.

NOTE 9.  LONG-TERM DEBT

Long-term debt consists of the following at September 30:
<TABLE>
<S>                                                                          <C>                  <C>

                                                                                   2005                 2004

                                                                             -----------------    ------------------

Term note in the amount of $4,300,000 dated June 16, 2005, payable in monthly
installments including interest at a rate of prime plus 1/2% (prime rate is
6.75% as of September 30, 2005) of $94,977 from July 2005 to June 2006 and
$76,033 from July 2006 to June 2009, maturing June 16, 2009, $
collateralized by substantially all assets of the Company.                   4,032,907            $
                                                                                                  --


Note payable in the amount of $1,600,000 with monthly installments of $13,328
including interest at 8% through January 1, 2009 collateralized by
accounts   receivable  from  patients  and  leasehold   interests  and  the  476,733              593,409
guarantee of the P.A.


Note payable to a financial institution in the amount of $280,000, dated May 11,
2002, with monthly installments including interest at a rate of prime plus 1.5%
(prime rate is 6.75% as of September 30, 2005) of $2,377 from May 2005 to June
2010, with a final payment of all remaining principal and accrued interest due
in June 2010, collateralized by a
mortgage on one of the Company's  medical  facilities with a net book value  153,250              170,982
of approximately $405,000.


Term note in the amount of $2,750,000  dated  February 9, 2004,  payable in
monthly  installments of $51,982 including interest at a rate of prime plus
1% (prime rate is 6.75% as of September  30,  2005),  maturing  February 9,
2009,  collateralized by accounts  receivable from patients.  The term note                --
was satisfied on June 16, 2005.                                                                   2,465,418
                                                                             -----------------    ------------------
                                                                             -----------------    ------------------

     Subtotal                                                                4,662,890            3,229,809



Capitalized  lease  obligation  with  monthly  payments of $16,195  through
March 16, 2006                                                               95,215               274,088
                                                                             -----------------    ------------------
                                                                                                  ------------------

                                                                             4,758,105            3,503,897
                                                                                  (1,259,315)
Less, current portion                                                                             (972,108)
                                                                             -----------------    ------------------
                                                                                                  ------------------
                                                                                   $                    $
Total Long-Term Debt                                                         3,498,790            2,531,789
                                                                             =================    ==================
</TABLE>

Aggregate maturities of notes payable and capital leases are as follows:

<TABLE>
<S>  <C>                             <C>                 <C>                  <C>

                                      Notes Payable      Capital Leases
Year ending September 30:                                                          Total
                                     ----------------    ----------------     ----------------
                                          $1,164,100           $  95,215           $1,259,315
     2006
                                             902,121                  --              902,121
     2007
                                             965,510                  --              965,510
     2008
                                           1,604,196                  --            1,604,196
     2009
                                              26,963                  --               26,963
     2010
                                     ----------------    ----------------     ----------------
                                          $4,662,890           $  95,215           $4,758,105

                                     ================    ================     ================
</TABLE>



<PAGE>


During fiscal year 2005, the Company borrowed $4,300,000 under a loan agreement
with Branch Banking & Trust Company of South Carolina to refinance an existing
term loan at more favorable terms and a lower interest rate in order the pay the
balance in full for all pre-petition taxes due to the Internal Revenue Service
and the South Carolina Department of Revenue. The agreement contains certain
restrictive covenants including restricting the purchase of capital assets in
excess of $1,500,000 during any fiscal year and requiring net worth of
$4,500,000 as of fiscal year end 2005 and increasing by at least the net profits
after taxes less approved dividends over the prior fiscal year end result each
fiscal year thereafter. The Company was in violation of one of its debt
covenants. The covenant requires that annual aggregate capital expenditures not
exceed $1,500,000. The Company has received a letter from the lender that has
waived the violation through September 30, 2005.

NOTE 10.  EMPLOYEE BENEFIT PLANS

The Company has an employee savings plan (the "Savings Plan") that qualifies as
a deferred salary arrangement under Section 401(k) of the Internal Revenue Code.
Under the Savings Plan, participating employees may defer a portion of their
pretax earnings, up to the Internal Revenue Service annual contribution limit.
The Company matches 100% of each employee's contribution up to a maximum of 6%
of the employee's earnings. The Company's matching contributions were
approximately $547,000, $439,000, and $277,000, in fiscal years 2005, 2004, and
2003, respectively.

During June 1997, the Company's Board of Directors approved the UCI/Doctors Care
Deferred Compensation Plan (the "Plan") for key employees of the Company with an
effective date of June 1998. To be eligible for the Plan, key employees must
have completed three years of full-time employment and hold a management or
physician position that is required to obtain specific operational goals that
benefit the Company as a whole. Under the Plan, key employees may defer a
portion of their after tax earnings with the Company matching three times the
employee's contribution percentage. The Company's matching contributions were
approximately $185,000, $130,000, and $118,000, in fiscal years 2005, 2004, and
2003, respectively.

During the fiscal year ended September 30, 1984, the Company adopted an
incentive stock plan (the "1984 Plan"). The 1984 Plan expired under its terms in
December 1993. At September 30, 2005, there were no stock options outstanding
under the 1984 Plan.

Pursuant to the Company's incentive stock option plan adopted in 1994, (the
"1994 Plan"), "incentive stock options", within the meaning of Section 422 of
the Internal Revenue Code, may be granted to employees of the Company. The 1994
Plan provides for the granting of options for the purchase of 750,000 shares at
100% of the fair market value of the stock at the date of grant (or for 10% or
higher shareholders, at 110% of the fair market value of the stock at the date
of grant). Options granted under the 1994 Plan vest at a rate of 33% in each of
the three years following the grant. Vested options become exercisable one year
after the date of grant and can be exercised within ten years of the date of
grant, subject to earlier termination upon cessation of employment. At September
30, 2005, stock options for 177,650 shares were outstanding under the 1994 Plan.

During the fiscal year ended September 30, 1996, the Company adopted a
Non-Employee Director Stock Option Plan (the "1996 Non-Employee Plan"). The 1996
Non-Employee Plan provides for the granting of options to two non-employee
directors for the purchase of 10,000 shares of the Company's common stock at the
fair market value as of the date of grant. Under this plan, 5,000 options were
issued to Harold H. Adams, Jr. and 5,000 options were issued to Russell J.
Froneberger. These options are exercisable during the period commencing on March
20, 1999 and ending on March 20, 2006. At September 30, 2005, stock options for
5,000 shares were outstanding under the 1996 non-employee plan, all of which
were exercisable.

During the fiscal year ended September 30, 1997, the Company adopted a
Non-Employee Director Stock Option Plan (the "1997 Non-Employee Plan"). The 1997
Non-Employee Plan provides for the granting of options to three non-employee
directors for the purchase of 20,000 shares of the Company's common stock at the
fair market value as of the date of grant. Under this plan, 5,000 options were
issued to Thomas G. Faulds, Ashby Jordan, M.D., and Charles M. Potok. These
options are exercisable during the period commencing on March 28, 2000 and
ending on March 28, 2007. At September 30, 2005, stock options for 10,000 shares
were outstanding under the 1997 non-employee plan, all of which were
exercisable.

NOTE 11.  STOCKHOLDERS' EQUITY

In February 1999, the shareholders approved an increase in the number of
authorized shares to 50,000,000. The following table summarizes activity and
weighted average fair value of options granted for the three previous fiscal
years for the Company's four stock option plans.


<TABLE>
<S>                               <C>             <C>             <C>               <C>

                                                                      1996               1997
                                    1984              1994         Non-Employee      Non-Employee
       Stock Options                Plan              Plan            Plan               Plan
-----------------------------                     -------------    ------------      -------------
                                  ----------      -------------    ------------      -------------

----------------------------- --- ---------- ---- ------------- -- ------------ ---- -------------
Outstanding at 09/30/02               9,300         340,650           10,000            15,000
                                  ----------      -------------    ------------      -------------
                                  ----------      -------------    ------------      -------------

  Exercisable at 09/30/02             9,300         340,650           10,000            15,000

  Forfeited FY 02/03                 (9,300)        (14,000)          (5,000)           (5,000)
                                  ----------      -------------    ------------      -------------
                                  ----------      -------------    ------------      -------------
Outstanding at 09/30/03                       --    326,650            5,000            10,000
                                  ----------      -------------    ------------      -------------
                                  ----------      -------------    ------------      -------------

  Exercisable at 09/30/03                --         326,650            5,000            10,000

  Forfeited FY 03/04                     --                 --              --                 --
                                  ----------      -------------    ------------      -------------
                                  ----------      -------------    ------------      -------------

Outstanding at 09/30/04                  --         326,650            5,000            10,000
                                  ----------      -------------    ------------      -------------
                                  ----------      -------------    ------------      -------------

  Exercisable at 09/30/04                --          326,650           5,000            10,000

  Forfeited FY 04/05                     --        (101,000)                --                 --
                                  ----------      -------------    ------------      -------------
                                  ----------      -------------    ------------      -------------

Outstanding at 09/30/05                  --         225,650            5,000            10,000
                                  ==========      =============    ============      =============
</TABLE>

The Company has not granted options under any plans during fiscal years 2005,
2004, and 2003 and there have been no shares exercised during 2005, 2004, or
2003.



<PAGE>


The following table summarizes the weighted average exercise price of stock
options exercisable at the end of each of the three previous fiscal years:

<TABLE>
<S>       <C>                            <C>              <C>              <C>                   <C>

                                                                                 1996                  1997
          Weighted Average                                                 Non-Employee Plan       Non-Employee
           Exercise Price                 1984 Plan        1994 Plan                                   Plan
-------------------------------------    -------------    -------------    ------------------    ------------------

             Outstanding at 09/30/02            $ .25           $ 2.63                $ 3.50                $ 2.50
                                         -------------    -------------    ------------------    ------------------
             Exercisable at 09/30/02              .25             2.63                  3.50                  2.50
                    Granted FY 02/03               --               --                    --                    --
                  Exercised FY 02/03               --               --                    --                    --
                  Forfeited FY 02/03               --             2.63                  3.50                  2.50
                                         -------------    -------------    ------------------    ------------------
                                         -------------    -------------    ------------------    ------------------
             Outstanding at 09/30/03              N/A           $ 2.63                $ 3.50                $ 2.50
                                         -------------    -------------    ------------------    ------------------
                                         -------------    -------------    ------------------    ------------------
             Exercisable at 09/30/03              N/A           $ 2.63                $ 3.50                $ 2.50
                    Granted FY 03/04               --               --                    --                    --
                  Exercised FY 03/04               --               --                    --                    --
                  Forfeited FY 03/04              N/A               --                    --                    --
                                         -------------    -------------    ------------------    ------------------
                                         -------------    -------------    ------------------    ------------------
             Outstanding at 09/30/04              N/A           $ 2.63                $ 3.50                $ 2.50
                                         -------------    -------------    ------------------    ------------------
                                         -------------    -------------    ------------------    ------------------
             Exercisable at 09/30/04              N/A           $ 2.63                $ 3.50                $ 2.50
                    Granted FY 04/05               --               --                    --                    --
                  Exercised FY 04/05               --               --                    --                    --
                  Forfeited FY 04/05              N/A               --                    --                    --
                                         -------------    -------------    ------------------    ------------------
                                         -------------    -------------    ------------------    ------------------
             Outstanding at 09/30/05              N/A           $ 2.63                $ 3.50                $ 2.50
                                         =============    =============    ==================    ==================
</TABLE>

The following table summarizes options outstanding and exercisable by price
range as of September 30, 2005:


<TABLE>
<S>                      <C>                 <C>                <C>             <C>               <C>

                                        Options Outstanding                          Options Exercisable


-------------------- --- --------------------------------------------------- -- ------------------------------

                                                Weighted
                                                Average          Weighted                          Weighted
                                               Remaining          Average                           Average
                                              Contractual        Exercise                          Exercise
  Range of Price          Outstanding             Life             Price         Exercisable         Price
--------------------     ---------------     ---------------    ------------    --------------    ------------


                                149,650                1.74            1.94           149,650            1.94
$1.00 to $1.99
                                 38,000                1.64            2.67            38,000            2.67
$2.00 to $2.99
                                 43,000                 .64            3.31            43,000            3.31
$3.00 to $3.99
                                 10,000                 .35            4.00            10,000            4.00
$4.00 to $4.99
                         ---------------                                        --------------
                                240,650                                               240,650

                         ===============                                        ==============
</TABLE>

The Company has adopted the disclosure-only provisions of SFAS No. 123,
"Accounting for Stock-Based Compensation." Accordingly, no compensation cost has
been recognized for the stock option plans. All of the stock options had fully
vested prior to October 1, 2000, and therefore, there was no compensatory effect
for the three years ended September 30, 2005. The Company has historically
calculated the fair value of stock options using the Black-Scholes
option-pricing model.
-------------------------------------------

-------------------------------------------
During the year ended September 30, 1997, warrants for the purchase of shares of
the Company's common stock were issued, ranging in exercise price from $1.9375
to $5.00. Fifty-five thousand (55,000) warrants were issued in connection with
services to be rendered by an investor relations advisor to the Company. During
the years ended September 30, 1998 and September 30, 1999, the Company granted
to the convertible debenture holder warrants to purchase up to thirty-five
thousand (35,000) and ten thousand (10,000) warrant shares, respectively, as
part of a $1,500,000 convertible subordinated debenture. The Stock Purchase
Warrant allows for 65,000 shares in total. In addition, during the year ended
September 30, 1999, the Company granted to Allen & Company Incorporated,
financial advisors, warrants to purchase 150,000 shares of common stock. No
warrants were issued during the three fiscal years ended September 30, 2005,
2004, and 2003. On March 1, 2004, the company issued 90,000 shares of common
stock to Allen & Company, Incorporated upon the exercise of its warrants issued
in March of 1999.

The following is a schedule of warrants issued and outstanding during the years
ended September 30, 2005, 2004 and 2003:

<TABLE>
<S>                                  <C>               <C>                  <C>                <C>

                                       Number of          Exercise              Date            Expiration
                                       Warrants            Price            Exercisable            Date
                                     --------------    ---------------     ---------------     --------------
                                     --------------
Outstanding at 09/30/02                    150,000              $1.00         03/03/99           03/03/04

Activity during FY 02/03:
    Exercised                                    --
    Expired                                      --
                                     --------------
                                     --------------
Outstanding at 09/30/03                    150,000               1.00         03/03/99           03/03/04
                                     --------------
                                     --------------

Activity during FY 03/04:
    Exercised                            (150,000)               1.00         03/03/99           03/03/04
    Expired                                     --
                                     --------------
                                     --------------
Outstanding at 09/30/04                        N/A
                                     --------------
                                     --------------

Activity during FY 04/05:
    Exercised                                    --
    Expired                                      --
                                     --------------
                                     --------------
Outstanding at 09/30/05                        N/A
                                     ==============
</TABLE>

NOTE 12.  LEASE COMMITMENTS

UCI-SC leases office and medical center space under various operating lease
agreements. Certain operating leases provide for escalation payments, exclusive
of renewal options.

Future minimum lease payments under noncancellable operating leases with a
remaining term in excess of one year as of September 30, 2005, are as follows:

<TABLE>
<S>                             <C>                                    <C>

                                                                           Operating
                                                                            Leases
                                                                        ----------------

                                 Year ending September 30:
                                   2006                                     $ 2,956,417
                                   2007                                       2,969,443
                                   2008                                       2,866,880
                                   2009                                       2,587,861
                                   2010                                       2,432,354
                                                                             20,662,074
                                    Thereafter
                                                                        ----------------
                                                                            $34,475,029
                                 Total minimum lease payments
                                                                        ================
</TABLE>

Total rental expense under operating leases for fiscal years 2005, 2004 and 2003
was approximately $2,700,000, $2,600,000, and $2,600,000, respectively.

NOTE 13.  RELATED PARTY TRANSACTIONS

Relationship between UCI-SC and the P.A.

     Pursuant  to  agreements  between  UCI-SC  and the  P.A.,  UCI-SC  provides
non-medical management services and personnel,  facilities,  equipment and other
assets  to the  medical  centers.  UCI-SC  guarantees  the  compensation  of the
physicians  employed by the P.A. The  agreements  also allow UCI-SC to negotiate
contracts  with  HMOs and  other  organizations  for the  provision  of  medical
services  by the P.A.  physicians.  Under the terms of the  agreement,  the P.A.
assigns all revenue  generated from providing  medical  services to UCI-SC after
paying  physician  salaries and the cost of narcotic  drugs held by the P.A. The
P.A. is owned by D. Michael Stout, M.D., who is also the Chief Executive Officer
for UCI and UCI-SC.

Relationship between the Company and Blue Cross Blue Shield of South Carolina

Blue Cross Blue Shield of South Carolina (BCBS) owns 100% of BlueChoice
HealthPlan ("BCHP") [formerly known as Companion HealthCare Corporation `CHC'],
Companion Property & Casualty Insurance Company ("CP&C") and Companion
Technologies, Inc. ("CT"). At September 30, 2005, BCHP owned 6,107,838 shares of
the Company's outstanding common stock and CP&C owned 618,181 shares of the
Company's outstanding common stock, which combine to approximately 69% of the
Company's outstanding common stock.

Facility Leases

Several of the medical center facilities operated by UCI-SC are leased or were
leased from entities owned or controlled by certain principal shareholders,
Board members, and/or members of the Company's management. Total lease payments
made by UCI-SC under these leases during the fiscal years ended September 30,
2005, 2004 and 2003, were approximately $96,000 for each year.

One medical facility operated by UCI-SC is leased from a physician employee of
the P.A. Total lease payments made by UCI-SC under these leases during the
Company's fiscal years ended September 30, 2005, 2004, and 2003, were
approximately $61,000, $61,000, and $50,000, respectively.

Other Transactions with Related Parties

At September 30, 2005, BCBS and its subsidiaries control 6,726,019 shares, or
approximately 69% of the Company's outstanding common stock. The shares acquired
by BlueChoice HealthPlan ("BCHP") [formerly known as Companion HealthCare
Corporation `CHC'] and Companion Property & Casualty Insurance Company ("CP&C")
from the Company were purchased pursuant to stock purchase agreements and were
not registered. BCHP and CP&C have the right to require registration of the
stock under certain circumstances as described in the agreement. BCBS and its
subsidiaries have the option to purchase as many shares as may be necessary for
BCBS to obtain ownership of 48% of the outstanding common stock of the Company
in the event that the Company issues additional stock to other parties
(excluding shares issued to employees or directors of the Company).

The Company enters into capital lease obligations with CT to purchase computer
equipment, software, and billing and accounts receivable upgrades. The total of
all lease obligations to CT recorded at September 30, 2005 is $95,000.

During the Company's fiscal year ended September 30, 1994, UCI-SC entered into
an agreement with CP&C pursuant to which UCI-SC, through the P.A., acts as the
primary care provider for injured workers of firms carrying worker's
compensation insurance through CP&C.

UCI-SC, through the P.A., provides services to members of a health maintenance
organization ("HMO") operated by BlueChoice HealthPlan ("BCHP") [formerly known
as Companion HealthCare Corporation `CHC'] who have selected the P.A. as their
primary care provider.

During fiscal years 2005, 2004, and 2003, the Company paid BCBS and its
subsidiaries approximately $15,000, $32,000, and $47,000, respectively, in
interest.

Revenues generated from billings to BCBS and its subsidiaries totaled
approximately 40%, 39%, and 38%, of the Company's total revenues for fiscal
years 2005, 2004, and 2003, respectively.

NOTE 14.  CONCENTRATION OF CREDIT RISK

In the normal course of providing health care services, the Company may extend
credit to patients without requiring collateral. Each individual's ability to
pay balances due the Company is assessed and reserves are established to provide
for management's estimate of uncollectible balances. Approximately 15% of the
Company's year end accounts receivable balance is due from Blue Cross Blue
Shield of South Carolina. No other single payor represents more than 5% of the
year end balance.

Future revenues of the Company are largely dependent on third-party payors and
private insurance companies, especially in instances where the Company accepts
assignment.

NOTE 15.  COMMITMENTS AND CONTINGENCIES

The Company is insured for professional and general liability on a claims-made
basis, with additional tail coverage being obtained when necessary.

The Company provides health benefits to its employees under a self-insured
health plan. Claims are paid by the Company up to an individual and aggregate
amount limit of $60,000 and $1,170,912, respectively. Claims in excess of these
limits are covered by a third-party insurance contract. Health benefit claims of
approximately $1,230,000, $923,000, and $618,000, respectively, for each of the
three fiscal years ended September 30, 2005, are included in these financial
statements. The Company has accrued estimated incurred but not reported health
claims of approximately $217,000 and $200,000 as of September 30, 2005 and
September 30, 2004, respectively.

In the ordinary course of conducting its business, the Company becomes involved
in litigation, claims, and administrative proceedings. Certain litigation,
claims, and proceedings were pending at September 30, 2005, and management
intends to vigorously defend the Company in such matters.

The health care industry is subject to numerous laws and regulations of federal,
state and local governments. These laws and regulations include, but are not
necessarily limited to, matters such as licensure, accreditation, government
health care program participation requirements, reimbursement for patient
services and Medicare and Medicaid fraud and abuse. Recently, government
activity has increased with respect to investigations and allegations concerning
possible violations of fraud and abuse statutes and regulations by health care
providers.

Violations of these laws and regulations could result in expulsion from
government health care programs together with the imposition of significant
fines and penalties, as well as significant repayments for patient services
previously billed. Management believes that the Company is in compliance with
fraud and abuse as well as other applicable government laws and regulations;
however, the possibility for future governmental review and interpretation
exists.

NOTE 16.  SUPPLEMENTAL CASH FLOW INFORMATION

Supplemental Disclosure of Cash Flow Information

The Company made interest payments of approximately $549,000, $693,000, and
$744,000, in the years ended September 30, 2005, 2004, and 2003, respectively.
The Company paid approximately $96,000 and $70,000, of income tax payments in
the year ended September 30, 2005 and 2004, respectively.



<PAGE>


NOTE 17.   QUARTERLY FINANCIAL DATA (unaudited)

The quarterly data below is based on the Company's fiscal periods.
<TABLE>
<S>                                         <C>                <C>                <C>               <C>

                                                             Fiscal Year Ended September 30, 2005
                                            -----------------------------------------------------------------------
                                            --------------- -- -------------- --- -------------- -- ---------------
                                              12/31/2004        03/31/2005         06/30/2005         09/30/2005
                                            ---------------    --------------     --------------    ---------------
                                            ---------------

Revenues                                       $12,194,000       $15,662,000        $14,000,000        $14,786,000
Operating Cost                                   9,154,000        11,579,000         10,328,000         11,249,000
Operating Margin                                 3,040,000         4,083,000          3,672,000          3,537,000
Net Income after Provision for
   Income Taxes                                  5,462,000           941,000            662,000            476,000
Basic Earnings per Common Share                        .56               .10                .07                .05
Diluted Earnings per Common Share                      .56               .10                .07                .05

</TABLE>

<TABLE>
<S>                                         <C>                <C>                <C>               <C>

                                                             Fiscal Year Ended September 30, 2004
                                            -----------------------------------------------------------------------
                                            --------------- -- -------------- --- -------------- -- ---------------
                                              12/31/2003        03/31/2004         06/30/2004         09/30/2004
                                            ---------------    --------------     --------------    ---------------
                                            ---------------

Revenues                                       $12,770,000       $11,490,000        $11,318,000        $11,896,000
Operating Cost                                   9,382,000         9,002,000          8,869,000          9,481,000
Operating Margin                                 3,388,000         2,488,000          2,448,000          2,416,000
Net Income after Provision for
   Income Taxes                                  1,298,000         1,124,000            236,000            555,000
Basic Earnings per Common Share                        .13               .12                .02                .06
Diluted Earnings per Common Share                      .13               .11                .02                .07

</TABLE>

NOTE 18.  SUBSEQUENT EVENTS

On October 20, 2005, Doctors Care opened a new location in Bluffton, South
Carolina.




<PAGE>


                                   SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

UCI MEDICAL AFFILIATES, INC.                                    Date

/s/ D. Michael Stout, M.D.                               December 12, 2005
--------------------------
D. Michael Stout, M.D.

Its:  President and Chief Executive Officer


Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has been signed below by the following persons on behalf of the registrant and
in the capacities and on the dates indicated.
<TABLE>
<S>                                              <C>                                    <C>

Signature                                         Title                                  Date

/s/ D. Michael Stout, M.D.                        President and                          December 12, 2005
--------------------------
D. Michael Stout, M.D.                            Chief Executive Officer

/s/ Jerry F. Wells, Jr., CPA                      Executive Vice President and           December 12, 2005
-----------------------------
Jerry F. Wells, Jr., CPA                          Chief Financial Officer

/s/ Harold H. Adams, Jr., CPCU                    Director                               December 12, 2005
------------------------------
Harold H. Adams, Jr., CPCU

/s/ Charles M. Potok                              Director                               December 12, 2005
--------------------
Charles M. Potok

/s/ Ashby Jordan, M.D.                            Director                               December 12, 2005
----------------------
Ashby Jordan, M.D.

/s/ John M. Little, Jr., M.D., MBA                Director                               December 12, 2005
----------------------------------
John M. Little, Jr., M.D., MBA

/s/ Timothy L. Vaughn, CPA                        Director                               December 12, 2005
--------------------------
Timothy L. Vaughn, CPA

/s/ Joseph A. Boyle, CPA                          Director                               December 12, 2005
------------------------
Joseph A. Boyle, CPA

/s/ Jean E. Duke, CPA                             Director                               December 12, 2005
---------------------
Jean E. Duke, CPA
</TABLE>




<PAGE>


                          UCI MEDICAL AFFILIATES, INC.
                                  EXHIBIT INDEX


<TABLE>
<S>     <C>                     <C>

         Exhibit Number        Description
         2.1                   Order of  Confirmation  of UCI  Medical  Affiliates,  Inc.  ("UCI")  Dated  August  7, 2002
                               Incorporated by reference to Exhibit 2.1 on the Form 8-K filed August 16, 2002)
         2.2                   Order of  Confirmation  of UCI Medical  Affiliates of South  Carolina  Dated August 5, 2002
                               (Incorporated by reference to Exhibit 2.2 on the Form 8-K filed August 16, 2002)
         2.3                   Order of  Confirmation  of UCI Medical  Affiliates  of Georgia,  Inc.  Dated August 7, 2002
                               (Incorporated by reference to Exhibit 2.3 on the Form 8-K filed August 16, 2002)
         2.4                   Order of  Confirmation  of  Doctors  Care,  P.A.  Dated  August  8, 2002  (Incorporated  by
                               reference to Exhibit 2.4 on the Form 8-K filed August 16, 2002)
         2.5                   Order  of  Confirmation   of  Doctors  Care  of  Tennessee,   P.C.  Dated  August  6,  2002
                               (Incorporated by reference to Exhibit 2.5 on the Form 8-K filed August 16, 2002)
         2.6                   Order of Confirmation of Doctors Care of Georgia,  P.C. Dated August 7, 2002  (Incorporated
                               by reference to Exhibit 2.6 on the Form 8-K filed August 16, 2002)
         2.7                   Plan of  Reorganization  for UCI  (Incorporated by reference to Exhibit 2.7 on the Form 8-K
                               filed August 16, 2002)
         2.8                   Plan of Reorganization  for UCI Medical  Affiliates of South Carolina,  Inc.  (Incorporated
                               by reference to Exhibit 2.8 on the Form 8-K filed August 16, 2002)
         2.9                   Plan of  Reorganization  of UCI  Medical  Affiliates  of  Georgia,  Inc.  (Incorporated  by
                               reference to Exhibit 2.9 on the Form 8-K filed August 16, 2002)
         2.10                  Plan of  Reorganization  of Doctors Care, P.A.  (Incorporated  by reference to Exhibit 2.10
                               on the Form 8-K filed August 16, 2002)
         2.11                  Plan of  Reorganization  of Doctors Care of Tennessee,  P.C.  (Incorporated by reference to
                               Exhibit 2.11 on the Form 8-K filed August 16, 2002)
         2.12                  Plan of  Reorganization  for Doctors Care of Georgia,  P.C.  (Incorporated  by reference to
                               Exhibit 2.12 on the Form 8-K filed August 16, 2002)
         2.13                  Joint  Disclosure  Statement Filed as of May 3, 2002  (Incorporated by reference to Exhibit
                               2.13 on the Form 8-K filed August 16, 2002)
         2.14                  Addendum to Joint  Disclosure  Statement and Plans of  Reorganization  Filed as of June 14,
                               2002 (Incorporated by reference to Exhibit 2.14 on the Form 8-K filed August 16, 2002)
         2.15                  Second  Addendum  to Plans of  Reorganization  Filed as of July 29, 2002  (Incorporated  by
                               reference to Exhibit 2.15 on the Form 8-K filed August 16, 2002)
         3.1                   Amended  and  Restated  Certificate  of  Incorporation  of  UCI  filed  with  the  Delaware
                               Secretary  of State as of July 27, 1994  (Incorporated  by reference to the exhibit of same
                               number on the Form 10-K filed for fiscal year 2003)
         3.2                   Amended and Restated Bylaws of UCI dated as of November 23, 1993
                               (Incorporated by reference to the exhibit of same number on the Form 10-K filed for
                               fiscal year 2003)
         3.3                   Amendment to Amended and Restated
                               Bylaws of UCI dated as of August 21,
                               1996 (Incorporated by reference to
                               the exhibit of same number on the
                               Form 10-K filed for fiscal year
                               2003)
</TABLE>



<PAGE>

<TABLE>
<S>     <C>                    <C>

         3.4                   Amendment to Amended and Restated
                               Bylaws of UCI dated as of August 15,
                               2002 (Incorporated by reference to
                               Exhibit 3.4 on the Form 8-K filed as
                               of October 28, 2002)
         3.5                   Certificate  of  Amendment  of  Certificate  of  Incorporation   filed  with  the  Delaware
                               Secretary of State as of February  24, 1999  (Exhibit 3.5 on the Form 10-K filed for fiscal
                               year 2002)
         4.1                   The  rights  of  security  holders  of the  registrant  are set  forth in the  registrant's
                               Certificate of Incorporation and Bylaws,  as amended,  included as Exhibits 3. 1 through 3.
                               5
         10.5                  Lease and License  Agreement  dated March 30, 1994  between  Doctors  Care,  P.A.  and Blue
                               Cross Blue  Shield of South  Carolina  (Incorporated  by  reference  to the exhibit of same
                               number on the Form 10-K filed for fiscal year 2003)
         10.6                  Note Payable dated  February 28, 1995 between UCI-SC as payor,  and Companion  Property and
                               Casualty  Insurance  Company,  as payee  (Incorporated  by reference to the exhibit of same
                               number on the Form 10-K filed for fiscal year 2003)
         10.7                  Revolving  Line of Credit  dated  November  11, 1996  between  Carolina  First Bank and UCI
                               Incorporated  by  reference  to the  exhibit  of same  number on the Form  10-K  filed for
                               fiscal year 2003)
         10.8**                Stock  Option  Agreement  dated  March  20,1996  between  UCI  and  Harold  H.  Adams,  Jr.
                               (Incorporated  by  reference  to the  exhibit  of same  number on the Form  10-K  filed for
                               fiscal year 2003)
         10.9**                Stock Option Agreement dated March 20, 1996 between UCI and
                               Russell J.  Froneberger  (Incorporated  by  reference  to the exhibit of same number on the
                               Form 10-K filed for fiscal year 2003)
         10.11**               Stock Option Agreement dated March 27, 1997, between UCI and
                               Thomas G.  Faulds  (Incorporated  by  reference  to the  exhibit of same number on the Form
                               10-K filed for fiscal year 2003)
         10.12**               Stock  Option  Agreement  dated  March  27,  1997  between  UCI  and  Ashby  Jordan,   M.D.
                               (Incorporated  by  reference  to the  exhibit  of same  number on the Form  10-K  filed for
                               fiscal year 2003)
         10.13**               Stock   Option   Agreement   dated  March  27,  1997  between  UCI  and  Charles  M.  Potok
                               (Incorporated  by  reference  to the  exhibit  of same  number on the Form  10-K  filed for
                               fiscal year 2003)
         10.14**               UCI 1994  Incentive  Stock  Option Plan  (Incorporated  by reference to the exhibit of same
                               number on the Form 10-K filed for fiscal year 2003)
         10.17                 Administrative  Services  Agreement  dated April 24, 1998 by and  between  Doctors  Care of
                               Georgia,  P.C. and UCI Medical  Affiliates of Georgia,  Inc.  (Incorporated by reference to
                               the exhibit of same number on the Form 10-K filed for fiscal year 2003)
         10.18                 Administrative  Services  Agreement  dated April 24, 1998 by and  between  Doctors  Care of
                               Tennessee,  P.C. and UCI Medical Affiliates of Georgia, Inc.  (Incorporated by reference to
                               the exhibit of same number on the Form 10-K filed for fiscal year 2003)
         10.19                 Administrative  Services  Agreement dated August 11, 1998 between UCI Medical Affiliates of
                               South Carolina,  Inc. and Doctors Care, P.A.  (Incorporated  by reference to the exhibit of
                               same number on the Form 10-K filed for fiscal year 2003)
         10.21                 Stock Purchase  Option and  Restriction  Agreement  dated September 1, 1998 by and among D.
                               Michael Stout, M.D.; UCI Medical  Affiliates of Georgia,  Inc. and Doctors Care of Georgia,
                               P.C.  (Incorporated  by  reference to the exhibit of same number on the Form 10-K filed for
                               fiscal year 2003)
</TABLE>


<PAGE>

<TABLE>
<S>     <C>                  <C>

         10.22               Stock Purchase Option and Restriction Agreement dated July 15, 1998    by and among D.
                             Michael Stout, M.D.; UCI Medical Affiliates of      Georgia, Inc.; and Doctors Care of Georgia,
                             P.C. (Incorporated by     reference to the exhibit of same number on the Form 10-K filed for
                             fiscal year 2003)
         10.31               Stock Purchase Option and  Restriction  Agreement dated as of October 31, 2002 by and among
                             D. Michael Stout, M.D.; UCI Medical  Affiliates of South Carolina,  Inc.; and Doctors Care,
                             P.A. (Incorporated by reference to Exhibit 10.31 filed on Form 10-K for fiscal year 2002)
         14                  Code of Ethics dated as of November 25, 2003  (Incorporated  by reference to the exhibit of
                             same number on the Form 10-K filed for fiscal year 2003)
         21                  Subsidiaries  of the  Registrant  (Incorporated  by reference to the exhibit of same number
                             on the Form 10-K filed for fiscal year 2003)
         23*                 Consent of Independent Auditors
         31.1*               Rule 13a-14(a)/15d-14(a) Certification of D. Michael Stout, M.D.
         31.2*               Rule 13a-14(a)/15d-14(a) Certification of Jerry F. Wells, Jr., CPA
         32*                 Section 1350 Certification
         99*                 Press Release dated December 12, 2005.
</TABLE>

         *Filed herewith

         ** Denotes a management contract or compensatory plan or arrangement.